| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. | Settheetham-Ishida, W Yuenyao, P Tassaneeyakul, W Kanjanavirojkul, N Thawmor, A Kularbkaew, C Hahvajanawong, C Settheetham, D Wattanathorn, J Kashima, T Ishida, T |
0 | ||||
| 2. | Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column. | Lambert, WE de Leenheer, AP Walgraeve, HR Tassaneeyakul, W |
1988 | ||||
| 3. | Anti-inflammatory activity of 5,7-dimethoxyflavone. | Panthong, A. Tassaneeyakul, W. Reutrakul, V. |
1989 | ||||
| 4. | A study of major causes and types of poisoning in Khonkaen, Thailand. | Chirasirisap, K Ussanawarong, S Tassaneeyakul, W Reungsritrakool, W Prasitwatanaseree, W Sripanyawit, U Premkamol, A Prasartthong, W Patitas, N |
1992 | ||||
| 5. | Caffeine as a probe for human cytochromes p450: Validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques | Tassaneeyakul, W Mohamed, Z Birkett, DJ McManus, ME Veronese, ME Tukey, RH Quattrochi, LC Gonzalez, FJ Miners, JO |
1992 | ||||
| 6. | Co-regulation of phenytoin and tolbutamide metabolism in humans | Tassaneeyakul, W Veronese, ME Birkett, DJ Doecke, CJ McManus, ME Sansom, LN Miners, JO |
1992 | ||||
| 7. | High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes. | Tassaneeyakul, W Veronese, ME Birkett, DJ Miners, JO |
1993 | ||||
| 8. | Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. | Tassaneeyakul, W. Tassaneeyakul, W. |
1993 | ||||
| 9. | Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. | Tassaneeyakul, W Birkett, DJ Veronese, ME McManus, ME Tukey, RH Quattrochi, LC Gelboin, HV Miners, JO |
1993 | ||||
| 10. | Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. | Tassaneeyakul, W Veronese, ME Birkett, DJ Gonzalez, FJ Miners, JO |
1993 | ||||
| 11. | Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. | Tassaneeyakul, W. McManus, M.E. Tassaneeyakul, W. |
1994 | ||||
| 12. | Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2. | Tassaneeyakul, W. McManus, M.E. |
1994 | ||||
| 13. | Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. | Tassaneeyakul, W Birkett, DJ Edwards, JW Veronese, ME Tukey, RH Miners, JO |
1996 | ||||
| 14. | Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 | Tassaneeyakul, W. Tassaneeyakul, W. |
1996 | ||||
| 15. | Limited value of the urinary phenotyoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo | Tassaneeyakul, W. | 1996 | ||||
| 16. | Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo. | Tassaneeyakul, W Birkett, DJ Pass, MC Miners, JO |
1996 | ||||
| 17. | Towards Understanding Cytochromes P450 | Wichittra Tassaneeyakul Wongwiwat Tassaneeyakul Khan Kaen Khon Kaen University |
1996 | ||||
| 18. | Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and non-steroidal anti-inflammatory agents. | Tassaneeyakul, W. | 1998 | ||||
| 19. | Antigastric Ulcer Effect of Turmeric in Rats | Patchareewan Pannangpetch Jintanaporn Watanathorn Orapin Phasuriwong Wichittra Tassaneeyakul Bunkerd Kongyingyoes |
2000 | ||||
| 20. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice | Tassaneeyakul, W Vannaprasaht, S Yamazoe, Y |
2000 | ||||
| 21. | Genetic Polymorphism of Cytochrome P450 2C19 | Wichittra Tassaneeyakul Arporn Tawalee Wongwiwat Tassaneeyakul |
2000 | ||||
| 22. | Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population | Wichittra Tassaneeyakul Arpom Tawalee Veerapol Kukongviriyapan Wongwiwat Tassaneeyakul |
2000 | ||||
| 23. | Inhibition selectivity of grapefruit juice components on human cytochromes P450 | Tassaneeyakul, W Guo, LQ Fukuda, K Ohta, T Yamazoe, Y |
2000 | ||||
| 24. | Arylamine N-Acetyltransferase-2 Genotype Polymorphism in Thai Population | Auemduan Prawan Veerapol Kukongviriyapan Wichittra Tassaneeyakul Bunkerd Kongyingyose Thailand 40002 Khon Kaen |
2001 | ||||
| 25. | Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. | Tassaneeyakul, W. Tawalee, A. Tassaneeyakul, W. Kukongviriyapan, V. Blaisdell, J.A. Goldstein, J.A. , |
2002 | ||||
| 26. | Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers | Wongwiwat Tassaneeyakul Arporn Tawalee Watchara Boonsawat Katcharin Phunikom Veerapol Kukongviriyapan Prapawadee Puapairoj Wichittra Tassaneeyakul |
2002 | ||||
| 27. | Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population | Somrudee Srimartpirom Wongwiwat Tassaneeyakul Veerapol Kukongwiriyapan Wichittra Tassaneeyakul |
2002 | ||||
| 28. | Screening for Naturally Occurring Inhibitors of Arylamine N-Acetyltransferase 1 Activity | Ninatthanan Phromsopha Veerapol Kukongviriyapan Wichittra Tassaneeyakul Upa Kukongviriyapan |
2002 | ||||
| 29. | Arylamine N-acetyltransferase-2 genotypes in the Thai population | Kukongviriyapan, V Prawan, A Tassaneyakul, W Aiemsa-Ard, J Warasiha, B |
2003 | ||||
| 30. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. | Tassaneeyakul, W Srimarthpirom, S Reungjui, S Chansung, K Romphruk, A Tassaneeyakul, W |
2003 | ||||
| 31. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] | Tassaneeyakul, W. Srimarthpirom, S. Reungjui, S. Chansung, G. Romphruk, A.V. Tassaneeyakul, W. |
2003 | ||||
| 32. | Evaluation of CYP1A2 Activity in Thalassemia Patients | Veerapol Kukongviriyapan Laddawan Senggunprai Upa Kukongviriyapan Arunee Jetsrisuparb Wichittra Tassaneyakul Khon Kaen 40002 Khon Kaen University |
2003 | ||||
| 33. | Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population | Kukongviriyapan, V Prawan, A Warasiha, B Tassaneyakul, W Aiemsa-ard, J |
2003 | ||||
| 34. | Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand. | Settheetham-Ishida, W. Singto, Y. Yuenyao, P. Tassaneeyakul, W. Kanjanavirojkul, N. Ishida, T. |
2004 | ||||
| 35. | Oxidative Stress and Protein Damage in Thalassemia Patients and Smokers | Nuntiya Somparn Veerapol Kukongviriyapan Wichitra Tassaneeyakul Upa Kukongviriyapan KhonKaen Khon Kaen University |
2004 | ||||
| 36. | Thiopurine S-methyltransferase genetic polymorphism in the Thai population. | Srimartpirom, S Tassaneeyakul, W Kukongviriyapan, V Tassaneeyakul, W |
2004 | ||||
| 37. | Thiopurine S-methyltransferase polymorphism in the Thai population | Tassaneeyakul, W. Kukongviriyapan, V. Tassaneeyakul, W. |
2004 | ||||
| 38. | Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma. | Prawan, A. Kukongviriyapan, V. Tassaneeyakul, W. Pairojkul, C. Bhudhisawasdi, V. |
2005 | ||||
| 39. | Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines | Nisana Tepsiri Liengchai Chaturat Banchob Sripa Wises Namwat Sopit Wongkham Vajarabhongsa Bhudhisawasdi Wichittra Tassaneeyakul |
2005 | ||||
| 40. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. | Tassaneeyakul, W. Kittiwattanagul, K. Vannaprasaht, S. Kampan, J. Tawalee, A. Puapairoj, P. Taimkao, S. Kukongviriyapan, V. Tassaneeyakul, W. |
2005 | ||||
| 41. | Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines | Nisana N. Tepsiri Watcharin Loilome Piyawan Amimanan Patcharee Jearanaikoon Wichittra Tassaneeyakul |
2006 | ||||
| 42. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. | Wichittra Tassaneeyakul Werawath Mahatthanatrakul Kanokporn Niwatananun Kesara Na-Bangchang Arporn Tawalee Nathawut Krikreangsak Utaiwan Cykleng Wongwiwat Tassaneeyakul |
2006 | ||||
| 43. | Effect of B-thalassemia/HbE disease on activity of cytochrome P450s | Nuntiya Somparn Veerapol Kukongviriyapan Wichittra Tassaneeyakul Upa Kukongviriyapan Arunee Jetsrisuparb |
2006 | ||||
| 44. | Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6. | Satarug, S. Tassaneeyakul, W. Na-Bangchang, K. |
2006 | ||||
| 45. | Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 | Kukongviriyapan, V Phromsopha, N Tassaneeyakul, W Kukongviriyapan, U Sripa, B Hahnvajanawong, V Bhudhisawasdi, V |
2006 | ||||
| 46. | Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in Northeastern Thailand | Settheetham-Ishida, W. Yuenyao, P. Tassaneeyakul, W. Kanjanavirojkul, N. Thawmor, A. Kularbkaew, C. Hahvajanawong, C. Settheetham, D. Wattanathorn, J. Kashima, T. Ishida, T. |
2006 | ||||
| 47. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis | Jitpimolmard, S Sawanyawisuth, K Morakote, N Vejjajiva, A Puntumetakul, M Sanchaisuriya, K Tassaneeyakul, W Tassaneeyakul, W Korwanich, N |
2007 | ||||
| 48. | Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients | Wichittra Tassaneeyakul Khanogwan Kittiwattanagul Siriporn Tiamkao Jureeporn Kampan Suda Vannaprasaht Wannapa Haewdee Prapawadee Puapairoj Bunkerd Kongyingyoes Wongwiwat Tassaneeyakul |
2007 | ||||
| 49. | COMPARATIVE BIOAVAILABILITY OF PHENYTOIN SUSPENSION IN THAI HEALTHY VOLUNTEERS | Suda Vannaprasaht Somsak Tiamkao Aporanee Chaiyakum Chedsada Noppawinyoowong Detpon Preechagoon Sirimas Kanjanawat Wichittra Tassaneeyakul |
2007 | ||||
| 50. | COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS | Sirimas Kanjanawart Suda Vannaprasaht Panot Tangsucharit Dhanu Gaysornsiri Siriporn Tiamkao Bunkerd Kongyingyoes Roongpet Tangrassameeprasert Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2007 | ||||
| 51. | Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines | Nisana Namwat Banchob Sripa Watcharin Loilome Vajarabhongsa Bhudisawadi Wichittra Tassaneeyakul |
2007 | ||||
| 52. | INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Vichien Attakornvattana Aimon Somanabandhu Suda Vannaprasaht Wongwiwat Tassaneeyakul |
2007 | ||||
| 53. | Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients | Nuntiya Somparn Upa Kukongviriyapan Wichittra Tassaneeyakul Arunee Jetsrisuparb Veerapol Kukongviriyapan |
2007 | ||||
| 54. | THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS | Susothorn Angsuthum Wichittra Tassaneeyakul Cholatip Pongskul Dhavee Sirivongs Wongwiwat Tassaneeyakul Yingyos Avihingsanon Suda Vannaprasaht |
2007 | ||||
| 55. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism | Boonsrirat, U Angsuthum, S Vannaprasaht, S Kongpunvijit, J Hirankarn, N Tassaneeyakul, W Avihingsanon, Y |
2008 | ||||
| 56. | Bioequivalence and Pharmacokinetic Study of Sildenafil in Healthy Thai Male Volunteers | Sirimas Kanjanawart Bunkerd Kongyingyoes Dhanu Gaysornsiri Panot Tangsucharit Prapawadee Puapairoj Suda Vannaprasaht Siriporn Tiamkao Wichittra Tassaneeyakul |
2008 | ||||
| 57. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines | Nisana Namwat Piyawan Amimanan Watcharin Loilome Patcharee Jearanaikoon Banchob Sripa Vajarabhongsa Bhudhisawasdi Wichittra Tassaneeyakul |
2008 | ||||
| 58. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers. | Tassaneeyakul, W. Kanchanawat, S. Gaysonsiri, D. Vannaprasath, S. Paupairoj, P. Kittiwattanagul, K. Tippabhotla, S.K. Khuroo, A.H. Panigrahy, B.K. Reyar, S. Monif, T. |
2008 | ||||
| 59. | GENETIC POLYMORPHISM OF DRUG METABOLIZING ENZYMES IN THAIS | Wichittra Tassaneeyakul | 2008 | ||||
| 60. | Herb and Drug Interaction | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Wongwiwat Tassaneeyakul |
2008 | ||||
| 61. | Monoclonal Antibody: Targeted Therapy of Cancer | Sirimas Kanjanawart Wichittra Tassaneeyakul |
2008 | ||||
| 62. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers | Tangsucharit, P Kampan, J Kanjanawart, S Gaysonsiri, D Vannaprasaht, S Tiamkao, S Phunikhom, K Simasathiansophon, S Puapairoj, P Tassaneeyakul, W |
2009 | ||||
| 63. | Cadmium exposure in thai populations from central, northern and northeastern thailand and the effects of food consumption on cadmium levels | Apinan, R Satarug, S Ruengweerayut, R Tassaneeyakul, W Na-Bangchang, K |
2009 | ||||
| 64. | Carbamazepine-the Most Common Cause of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and an Association with HLA-B*1502 in a Thai Population | Thawinee Iantararoungtong Somsak Tiamkao Suda Vannaprasaht Kasemsin Pavakul Narong Auvichayapat Charoen Choonhakarn Wichittra Tassaneeyakul |
2009 | ||||
| 65. | CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking | Mahavorasirikul, W. Tassaneeyakul, W. Satarug, S. Reungweerayut, R. Na-Bangchang, C. Na-Bangchang, K. |
2009 | ||||
| 66. | Effect of Albumin on In Vitro Omeprazole Kinetics in Human Liver Microsomes | Nitsupa Wattanachai David J. Elliot Wichittra Tassaneeyakul John O. Miners |
2009 | ||||
| 67. | Expression Profile of Genes Involved in 5-Fluorouracil Metabolic Pathway as Predictive Parameters for 5-Fluorouracil Response in Cholangiocarcinoma | Jariya Chaiyagool Chariya Hahnvajanawong Banchob Sripa Vajarapong Bhudhisawasdi Narong Khuntikeo Ake Pugkhem Siri Chau-in Wichittra Tassaneeyakul |
2009 | ||||
| 68. | Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand | Vannaprasaht, S Angsuthum, S Avihingsanon, Y Sirivongs, D Pongskul, C Makarawate, P Praditpornsilpa, K Tassaneeyakul, W Tassaneeyakul, W |
2009 | ||||
| 69. | Influence of Genetic and Environmental Factors on Cytochrome P450-mediated Nicotine Metabolism in Thai Population | Wiratchanee Mahavorasirikul Rungnapa Apinan Soisungwan Satarug Wichittra Tassaneeyakul Kesara Na-Bangchang |
2009 | ||||
| 70. | Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus | Theerada Taesotikul Aimon Somanabandhu Vichien Navinpipatana Sirimas Kanjanawart Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2009 | ||||
| 71. | Pharmacogenomics | Wichittra Tassaneeyakul | 2009 | ||||
| 72. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Tassaneeyakul, W Jantararoungtong, T Chen, P Lin, PY Tiamkao, S Khunarkornsiri, U Chucherd, P Konyoung, P Vannaprasaht, S Choonhakarn, C Pisuttimarn, P Sangviroon, A Tassaneeyakul, W |
2009 | ||||
| 73. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population. | Apinan, R. Tassaneeyakul, W. Mahavorasirikul, W. Satarug, S. Vannaprasaht, S. Ruenweerayut, R. Na-Bangchang, K. |
2009 | ||||
| 74. | Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 | Wongwiwat Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Pachadaporn Chucherd Suda Vannaprasaht Charoen Choonhakarn Alisara Sangviroon Wichittra Tassaneeyakul |
2010 | ||||
| 75. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. | Chariya Hahnvajanawong Wongwarut Boonyanugomol Tapanawan Nasomyon Watcharin Loilome Nisana Namwat Natthinee Anantachoke Wichittra Tassaneeyakul Banchob Sripa Wises Namwat Vichai Reutrakul |
2010 | ||||
| 76. | Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. | Wichittra Tassaneeyakul Somsak Tiamkao Thawinee Jantararoungtong Pei Chen Shu-Yi Lin Wei-Hsuan Chen Parinya Konyoung Usanee Khunarkornsiri Narong Auvichayapat Kasemsin Pavakul Kongkiat Kulkantrakorn Charoen Choonhakarn Siranun Phonhiamhan Namfon Piyatrakul Thiti Aungaree Sunsanee Pongpakdee Praphan Yodnopaglaw |
2010 | ||||
| 77. | Association of HLA-B*1502 and severe cutaneous adverse reactions caused by aromatic antiepileptic drugs | Wichittra Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Shu-Yi Lin Wei-Hsuan Chen Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Alisara Sangviroon Patcharee Kanjanawat Arkhom Arayawhichanont Charoen Choonhakarn Kongkiat Kulkantrakorn |
2010 | ||||
| 78. | Bioequivalence of 400 mg Moxifloxacin Tablet in Healthy Thai Volunteers | Sirimas Kanjanawart Sontaya Simasathiansopon Prapawadee Paupairoj Suda Vannaprasath Siriporn Tiamkao Dhanu Gaysonsiri Panot Tangsucharit Thanawat Kaewkamson Wichittra Tassaneeyakul |
2010 | ||||
| 79. | Carbamazepine- but not Phenytoin-induced Severe Cutaneous Adverse Drug Reactions are Associated with HLA-B*1502 in a Thai Population | Napat Prabmeechai Somsak Tiamkao Thawinee Jantararoungtong Pansu Chumworathayi Piyameth Dilokthornsakul Wichittra Tassaneeyakul |
2010 | ||||
| 80. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration. | Tassaneeyakul, W. Kumar, S.M. Gaysonsiri, D. Kaewkamson, T. Khuroo, A.H. Tangsucharit, P. Phunikhom, K. Vannaprasaht, S. Kanjanawart, S. Rao Thudi, N. Jain, R.K. Reyar, S. Monif, T. |
2010 | ||||
| 81. | Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation | Hasaya Dokduang Nisana Namwat Apinya Jusakul Vajarabhongsa Bhudisawadi Watcharin Loilome Puangrat Yongvanit Banchob Sripa Wichittra Tassaneeyakul |
2010 | ||||
| 82. | Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data | Nitsupa Wattanachai David J. Elliot Verawan Uchaipichat Wichittra Tassaneeyakul John O. Miners |
2010 | ||||
| 83. | OPTIMISING CLOZAPINE THERAPY: A NEW MODEL OF CLOZAPINE THERAPEUTIC DRUG MONITORING | John Ray Gillian Campbell Tony Richardson Gill Erickson Vaughan Carr Peter Rofe Wichittra Tassaneeyakul Gary Graham |
2010 | ||||
| 84. | Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin | Sangviroon, A Panomvana, D Tassaneeyakul, W Namchaisiri, J |
2010 | ||||
| 85. | Selective Inhibition of Human Cytochrome P450 1A2 by Moringa oleifera | Theerada Taesotikul Vichien Navinpipatana Wichittra Tassaneeyakul |
2010 | ||||
| 86. | The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation | Nitsupa Wattanachai Wichittra Tassaneeyakul Verawan Uchaipichat John O. Miners |
2010 | ||||
| 87. | Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme | Feng, Q Vannaprasaht, S Peng, Y Angsuthum, S Avihingsanon, Y Yee, VC Tassaneeyakul, W Weinshilboum, RM |
2010 | ||||
| 88. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers. | Kanjanawart, S. Gaysonsiri, D. Tangsucharit, P. Vannaprasaht, S. Phunikhom, K. Kaewkamson, T. Wattanachai, N. Tassaneeyakul, W. |
2011 | ||||
| 89. | Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines | Chariya Hahnvajanawong Vajarabhongsa Bhudisawadi Nisana Namwat Banchob Sripa Wichittra Tassaneeyakul |
2011 | ||||
| 90. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. | Namwat, N. Puetkasichonpasutha, J. Loilome, W. Yongvanit, P. Techasen, A. Puapairoj, A. Sripa, B. Tassaneeyakul, W. Khuntikeo, N. Wongkham, S. |
2011 | ||||
| 91. | HLA genetic polymorphism and severe cutaneous adverse drug reactions in a Thai population | Wichittra Tassaneeyakul | 2011 | ||||
| 92. | Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines | Chariya Hahnvajanawong Supaluk Ketnimit Wongwarut Boonyanugomol Kovit Pattanapanyasat Yaovalux Chamgramol Banchob Sripa Nisana Namwat Khosit Pinmai Wichittra Tassaneeyakul Vichai Reutakul |
2011 | ||||
| 93. | Inhibition of human CYP1A2 activity by Thai medicinal plants with promising activities against cholangiocarcinoma | Wiratchanee Mahavorasirikul Vithoon Viyanant Wichittra Tassaneeyakul Kesara Na-Bangchang |
2011 | ||||
| 94. | Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. | Theerada Taesotikul Weeraya Dumrongsakulchai Nitsupa Wattanachai Vichien Navinpipat Aimon Somanabandhu Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2011 | ||||
| 95. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Wattanachai, N Polasek, TM Heath, TM Uchaipichat, V Tassaneeyakul, W Tassaneeyakul, W Miners, JO |
2011 | ||||
| 96. | Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance | Wattanachai, N. Tassaneeyakul, W. |
2012 | ||||
| 97. | Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats | Taesotikul, T. Tassaneeyakul, W. |
2012 | ||||
| 98. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma | Yongvanit, P. Phanomsri, E. Namwat, N. Kampan, J. Tassaneeyakul, W. Loilome, W. Puapairoj, A. Khuntikeo, N. |
2012 | ||||
| 99. | High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma. | Umaporn Srimunta Kanlayanee Sawanyawisuth Ratthaphol Kraiklang Chawalit Pairojkul Anucha Puapairoj Tanin Titipungul Chariya Hahnvajanawong Wichittra Tassaneeyakul Chaisiri Wongkham Sopit Wongkham Kulthida Vaeteewoottacharn |
2012 | ||||
| 100. | HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain | Kongkiat Kulkantrakorn Wichittra Tassaneeyakul Somsak Tiamkao Thawinee Jantararoungtong Napat Prabmechai Suda Vannaprasaht Pansu Chumworathayi Pei Chen Paskorn Sritipsukho |
2012 | ||||
| 101. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil | Hahnvajanawong, C. Chaiyagool, J. Seubwai, W. Bhudhisawasdi, V. Namwat, N. Khuntikeo, N. Sripa, B. Pugkhem, A. Tassaneeyakul, W. |
2012 | ||||
| 102. | Suppression of PRKAR1A expression enhances antiproliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma Cells | Loilome, W Juntana, S Pinitsoontorn, C Namwat, N Tassaneeyakul, W Yongvanit, P |
2012 | ||||
| 103. | The Common Sodium Channel Promoter Haplotype in Thai Symptomatic Brugada Syndrome Patients | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Koo Seok Hwee Edmund Jon Deoon Lee Wichittra Tassaneeyakul |
2012 | ||||
| 104. | Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. | Callaghan, J.T. Tassaneeyakul, W. Lee, M.T.M. |
2013 | ||||
| 105. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers. | Kanjanawart, S. Gaysonsiri, D. Phunikom, K. Tangsucharit, P. Vannaprasaht, S. Kaewkamson, T. Tassaneeyakul, W. |
2013 | ||||
| 106. | Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy. | Auvichayapat, N Rotenberg, A Gersner, R Ngodklang, S Tiamkao, S Tassaneeyakul, W Auvichayapat, P |
2013 | ||||
| 107. | Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation | Vannaprasaht, S Reungjui, S Supanya, D Sirivongs, D Pongskul, C Avihingsanon, Y Tassaneeyakul, W |
2013 | ||||
| 108. | Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. | Wimonchat Tangamornsuksan Nathorn Chaiyakunapruk Ratchadaporn Somkrua Manupat Lohitnavy Wichittra Tassaneeyakul |
2013 | ||||
| 109. | Role of Human Leukocyte Antigens on Severe Cutaneous Drug Reactions | Thachanan Kongpan Usanee Khunakornsiri Prarinya Konyoung Pansu Chumworathayi Napat Pabmeechai Sirimas Kanjanawart Wichittra Tassaneeyakul |
2013 | ||||
| 110. | Transcranial Direct Current Stimulation for Treatment of Refractory Childhood Focal Epilepsy | Auvichayapat, N. Rotenberg, A. Gersner, R. Ngodklang, S. Tiamkao, S. Tassaneeyakul, W. Auvichayapat, P. |
2013 | ||||
| 111. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand. | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Tassaneeyakul, W. Sawanyawisuth, K. |
2014 | ||||
| 112. | COMPARATIVE ANTIPLATELET AGGREGATION EFFECT OF TWO CLOPIDOGREL PRODUCTS UNDER STEADY STATE CONDITION IN HEALTHY VOLUNTEERS | S. Tiamkao N. Nakkam S. Kanjanawart W. Tassaneeyakul |
2014 | ||||
| 113. | Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population | Saokaew, S Tassaneeyakul, W Maenthaisong, R Chaiyakunapruk, N |
2014 | ||||
| 114. | Determination of Melatonin in Plasma by Liquid-liquid Extraction and High Performance Liquid Chromatography Coupled with Fluorescence Detection and Its Application for Melatonin Pharmacokinetic Study in Humans | Nuttawut Jenjirattithigarn Katcharin Phunikom Thachanan Kongpan Sirimas Kanjanawart Jeffrey Roy Johns Wichittra Tassaneeyakul |
2014 | ||||
| 115. | High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis | Thongchot, S. Yongvanit, P. Loilome, W. Seubwai, W. Phunicom, K. Tassaneeyakul, W. Pairojkul, C. Promkotra, W. Techasen, A. Namwat, N. |
2014 | ||||
| 116. | HLA-B*58:01 Genotype is Associated With Risk of Severe Cutaneous Reactions Induced by Allopurinol in Patients Admitted in Udonthani Hospital | Usanee Khunakornsiri Prarinya Konyoung Thachanan Kongpan Supanida Kwangsukstid Sirimas Kanjanawart Wichittra Tassaneeyakul |
2014 | ||||
| 117. | Incidence of Drug induced-Acute Generalized Exanthematous Pustulosis (AGEP) Reported in Udonthani Hospital | Prarinya Konyoung Wichittra Tassaneeyakul |
2014 | ||||
| 118. | Outcomes of symptomatic Brugada syndrome patients with implanted cardioverter defibrillators: A report from an endemic area | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Tassaneeyakul, W. Sawanyawisuth, K. |
2014 | ||||
| 119. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. | Jurairat Jongthawin Porncheera Chusorn Anchalee Techasen Watcharin Loilome Thidarut Boonmars Raynoo Thanan Anucha Puapairoj Narong Khuntikeo Wichittra Tassaneeyakul Puangrat Yongvanit Nisana Namwat |
2014 | ||||
| 120. | Pharmacogenomics of drug-induced hypersensitivity reactions: challenges opportunities and clinical implementation | Puangpetch, A. Tassaneeyakul, W. |
2014 | ||||
| 121. | Pharmacology and Factors Affecting the Therapeutic Efficacy of Clopidogrel | Nontaya Nakkam Sirimas Kanjanawart Somsak Tiamkao Wichittra Tassaneeyakul |
2014 | ||||
| 122. | Pharmacology and Factors Affecting the Therapeutic Efficacy of Elopidogrel | Nontaya Nakkam Sirimas Kanjanawart Somsak Tiamkao Wichittra Tassaneeyakul |
2014 | ||||
| 123. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. | Kongpan, T. Mahasirimongkol, S. Kanjanawart, S. Chumworathayi, P. Mootsikapun, P. Vannaprasaht, S. Tassaneayakul, W. Tassaneeyakul, W. |
2015 | ||||
| 124. | Different Enzyme Cocktail Conditions Successfully Establish Primary Brain Tumor Cell Line Derived from Pilomyxoid Astrocytoma Patient | Wiyada Punjaruk Nitsa Pasasuk Amnat Kitkhuandee Paradee Auvichayapat Wichittra Tassaneeyakul |
2015 | ||||
| 125. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions | Nakkam, N Tiamkao, S Kanjanawart, S Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2015 | ||||
| 126. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. | Wichittra Tassaneeyakul Napat Prabmeechai Chonlaphat Sukasem Thachanan Kongpan Parinya Konyoung Pansu Chumworathayi Somsak Tiamkao Usanee Khunarkornsiri Kongkiat Kulkantrakorn Niwat Saksit Nontaya Nakkam Patompong Satapornpong Suda Vannaprasaht Alisara Sangviroon Surakameth Mahasirimongkol Nuanjun Wichukchinda Ticha Rerkpattanapipat Wongwiwat Tassaneeyakul |
2016 | ||||
| 127. | Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. | Y. Saito L. K. Stamp K. E. Caudle M. S. Hershfield E. M. McDonagh J. T. Callaghan W. Tassaneeyakul T. Mushiroda N. Kamatani B. R. Goldspiel E. J. Phillips T. E. Klein M. T. M. Lee |
2016 | ||||
| 128. | CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network | Callaghan, J.T. Tassaneeyakul, W. Lee, M.T.M. |
2016 | ||||
| 129. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 | ||||
| 130. | The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy | Duanggamon Muengsaen Suda Vannaprasaht Wichittra Tassaneeyakul Kritiya Butthongkomvong Thipawan Bowornkitiwong Luangyot Thongthieang Parichart Pongthai Kosin Wirasorn Aumkhae Sookprasert |
2016 | ||||
| 131. | Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population | Koomdee, N Pratoomwun, J Jantararoungtong, T Theeramoke, V Tassaneeyakul, W Klaewsongkram, J Rerkpattanapipat, T Santon, S Puangpetch, A Intusoma, U Tempark, T Deesudchit, T Satapornpong, P Visudtibhan, A Sukasem, C |
2017 | ||||
| 132. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Kutcharin Phunikhom Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2017 | ||||
| 133. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers . | Nakkam, N Tiamkao, S Kanjanawart, S Phunikhom, K Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2017 | ||||
| 134. | Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions | Nakkam, N Chumworathayi, P. Kanjanawart, S. Tassaneeyakul, W. |
2017 | ||||
| 135. | CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION | Wichittra Tassaneeyakul Parinya Konyoung Thachanan Kongpan Pansu Chumworathayi Nontaya Nakkam Suda Vannaprasaht Somsak Tiamkao Chonlaphat Sukasem Patompong Satapornpong Wongwiwat Tassaneeyakul |
2017 | ||||
| 136. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. | Therdpong Tempark Patompong Satapornpong Pawinee Rerknimitr Nontaya Nakkam Niwat Saksit Penpun Wattanakrai Thawinee Jantararoungtong Napatrupron Koomdee Ajanee Mahakkanukrauh Wichittra Tassaneeyakul Sumitra Suttisai Jirawat Pratoomwun Jettanong Klaewsongkram Ticha Rerkpattanapipat Chonlaphat Sukasem |
2017 | ||||
| 137. | DEVELOPMENT OF A PHARMACOGENETICS-BASED WARFARIN DOSING ALGORITHM FOR THAI PATIENTS | Nitsupa Wattanachai Sutthida Kaewmoongkun Wichittra Tassaneeyakul |
2017 | ||||
| 138. | GENETIC MARKERS FOR SEVERE CUTANEOUS ADVERSE DRUG REACTIONS IN THAI POPULATION AND THEIR CLINICAL STATUS | Wichittra Tassaneeyakul | 2017 | ||||
| 139. | HAPLOTYPE OF HLA-B*13:01/HLA-B*15:02 AND DAPSONE-INDUCED DRUG HYPERSENSITIVITY SYNDROME IN THAI | Chonlaphat Sukasem Therdpong Tempark Patompong Satapornpong Pawinee Rerknimitr Jettanong Klaewsongkram Wichittra Tassaneeyakul |
2017 | ||||
| 140. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance | Yothaisong, S Namwat, N Yongvanit, P Khuntikeo, N Puapairoj, A Jutabha, P Anzai, N Tassaneeyakul, W Tangsucharit, P Loilome, W |
2017 | ||||
| 141. | Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication | Mairiang, P. Vannaprasaht, S. Tassaneeyakul, W. Sangchan, A. Sawadpanich, K. |
2017 | ||||
| 142. | Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians | Chun-Bing Chen Yi-Hsin Hsiao Tony Wu Mo-Song Hsih Wichittra Tassaneeyakul Teekayu P. Jorns Chonlaphat Sukasem Chien-Ning Hsu Shih-Chi Su Wan-Chun Chang Rosaline Chung-Yee Hui Chia-Yu Chu Yi-Ju Chen Ching-Ying Wu Chao-Kai Hsu Tsu-Man Chiu Pei-Lun Sun Hua-En Lee Chin-Yi Yang Pei-han Kao Chih-Hsun Yang Hsin-Chun Ho Jing-Yi Lin Ya-Ching Chang Ming-Jing Chen Chun-Wei Lu Chau Yee Ng Kang-Ling Kuo Chien-yio Lin Ching-Sheng Yang Ding-Ping Chen Pi-Yueh Chang Tsu-Lan Wu Yu-Jr Lin Yi-Ching Weng Tseng-tong Kuo Shuen-Iu Hung Wen-Hung Chung |
2017 | ||||
| 143. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Saksit, N Tassaneeyakul, W Nakkam, N Konyoung, P Khunarkornsiri, U Chumworathayi, P Sukasem, C Suttisai, S Piriyachananusorn, N Tiwong, P Chaiyakunapruk, N Sawanyawisuth, K Rerkpattanapipat, T Tassaneeyakul, W |
2017 | ||||
| 144. | SCN5A genetic polymorphisms associated with increased defibrillator shocks in Brugada syndrome | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Dujdao Sahasthas Seok Hwee Koo Edmund Jon Deoon Lee Wichittra Tassaneeyakul Hector Barajas-Martinez Dan Hu Kittisak Sawanyawisuth |
2017 | ||||
| 145. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients. | Nitsupa Wattanachai Sutthida Kaewmoongkun Burabha Pussadhamma Pattarapong Makarawate Chaiyasith Wongvipaporn Songsak Kiatchoosakun Suda Vannaprasaht Wichittra Tassaneeyakul |
2017 | ||||
| 146. | Cost-effectiveness analysis of HLA-B ∗ 58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population | Huey Yi Chong Yi Heng Lim Juthamas Prawjaeng Wichittra Tassaneeyakul Zahurin Mohamed Nathorn Chaiyakunapruk |
2018 | ||||
| 147. | Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminai neuralgia | Chutikorn Khuankaew Nattayaporn Apaijai Passakorn Sawaddiruk Thidarat Jaiwongkann Sasiwan Kerdphoo Surawut Pongsiriwet Wichittra Tassaneeyakul Nipon Chattipakorn Siriporn C. Chattipakorn |
2018 | ||||
| 148. | Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia. | Tassaneeyakul, W. | 2018 | ||||
| 149. | HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population | Nontaya Nakkam Parinya Konyoung Sirimas Kanjanawart Niwat Saksit Thachanan Kongpan Kanyarat Khaeso Usanee Khunarkornsiri Areerat Domsena Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2018 | ||||
| 150. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 | ||||
| 151. | New advances in drug hypersensitivity research and treatment | Yi-Giien Tsai Wen-Hung Chung Riichiro Abe Wichittra Tassaneeyakul |
2018 | ||||
| 152. | Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. | Nakkam, N Konyoung, P Kanjanawart, S Saksit, N Kongpan, T Khaeso, K Khunarkornsiri, U Dornsena, A Tassaneeyakul, W Tassaneeyakul, W |
2018 | ||||
| 153. | HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians | Su, SC Chen, CB Chang, WC Wang, CW Fan, WL Lu, LY Nakamura, R Saito, Y Ueta, M Kinoshita, S Sukasem, C Yampayon, K Kijsanayotin, P Nakkam, N Saksit, N Tassaneeyakul, W Aihara, M Lin, YJ Chang, CJ Wu, T Hung, SI Chung, WH |
2019 | ||||
| 154. | Identification of drug-specific public TCR driving severe cutaneous adverse reactions. | Pan, R.Y. Tassaneeyakul, W. Chung, W.H. |
2019 | ||||
| 155. | Long term stability of immunophenotypic T cell subsets from whole blood of tacrolimus-based therapy kidney transplantation patients and healthy volunteers by flow cytometric analysis | Wongratanacheewin, S. Kaewraemruaen, C. Vannaprasaht, S. |
2019 | ||||
| 156. | Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect | Leong, SL Chaiyakunapruk, N Tassaneeyakul, W Arunmanakul, P Nathisuwan, S Lee, SWH |
2019 | ||||
| 157. | The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label. | Yu-Hsin Wang Chun-Bing Chen Wichittra Tassaneeyakul Yoshiro Saito Michiko Aihara Siew Eng Choon Haur Yueh Lee Mimi Mee Chang Francisca D. Roa Cheng-Wei Wu Jing Zhang Nontaya Nakkam Parinya Konyoung Yoshimi Okamoto-Uchida Christina Man-tung Cheung Jin-wen Huang Chao Ji Bo Cheng Rosaline Chung-Yee Hui Chia-Yu Chu Yi-Ju Chen Ching-Ying Wu Chao-Kai Hsu Tsu-Man Chiu Yu-Huei Huang Chun-Wei Lu Chin-Yi Yang Yi-Ting Lin Min-Hui Chi Hsin-Chun Ho Jing-Yi Lin Chih-Hsun Yang Ya-Ching Chang Shih-Chi Su Chuang Wei Wang Wen-Lang Fan Shuen-Iu Hung Wen-Hung Chung |
2019 | ||||
| 158. | The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label | Nakkam, N | 2019 | ||||
| 159. | Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. | Chonlaphat Sukasem Jirawat Pratoomwun Patompong Satapornpong Jettanong Klaewsongkram Ticha Rerkpattanapipat Pawinee Rerknimitr Pattamon Lertpichitkul Apichaya Puangpetch Nontaya Nakkam Parinya Konyoung Usanee Khunarkornsiri Wareeporn Disphanurat Chutika Srisuttiyakorn Oranuch Pattanacheewapull Sirimas Kanjanawart Thachanan Kongpan Pansu Chumworathayi Niwat Saksit Jackrapong Bruminhent Wichittra Tassaneeyakul Wasun Chantratita Munir Pirmohamed |
2020 | ||||
| 160. | Prevalence of CYP2C19, CYP3A4 and FMO3 genetic polymorphisms in healthy northeastern Thai volunteers | Kanjanawart, S. Nakkam, N. Tassaneeyakul, W. |
2020 | ||||
| 161. | Protective effects of purple waxy corn on aflatoxin B1-induced oxidative stress and micronucleus in HepG2 cells | T. Singto W. Tassaneeyakul S. Porasuphatana |
2020 | ||||
| 162. | Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing . | Pratoomwun, J Thomson, P Jaruthamsophon, K Tiyasirichokchai, R Jinda, P Rerkpattanapipat, T Tassaneeyakul, W Nakkam, N Rerknimitr, P Klaewsongkram, J Srinoulprasert, Y Pirmohamed, M Naisbitt, DJ Sukasem, C |
2021 | ||||
| 163. | Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01 | Jirawat Pratoomwun Paul Thomson Kanoot Jaruthamsophon Rawiporn Tiyasirichokchai Pimonpan Jinda Ticha Rerkpattanapipat Wichittra Tassaneeyakul Nontaya Nakkam Pawinee Rerknimitr Jettanong Klaewsongkram Yuttana Srinoulprasert Munir Pirmohamed Dean J. Naisbitt Chonlaphat Sukasem |
2021 | ||||
| 164. | Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients. | Kanyarat Khaeso Nontaya Nakkam Patcharee Komwilaisak Piyathida Wongmast Su-on Chainansamit Areerat Dornsena Sirimas Kanjanawart Suda Vannaprasaht Wichittra Tassaneeyakul |
2021 | ||||
| 165. | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine | Nontaya Nakkam Parinya Konyoung Warayuwadee Amornpinyo Niwat Saksit Somsak Tiamkao Usanee Khunarkornsiri Kanyarat Khaeso Oranuch Pattanacheewapull Teekayu Plangkoon Jorns Pansu Chumworathayi Wichittra Tassaneeyakul |
2021 | ||||
| 166. | HLA-B*13:01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Nakkam, N. Mahakkanukrauh, A. Jantararoungtong, T. Tassaneeyakul, W. |
2021 | ||||
| 167. | Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. | Satapornpong, P Pratoomwun, J Rerknimitr, P Klaewsongkram, J Nakkam, N Rungrotmongkol, T Konyoung, P Saksit, N Mahakkanukrauh, A Amornpinyo, W Khunarkornsiri, U Tempark, T Wantavornprasert, K Jinda, P Koomdee, N Jantararoungtong, T Rerkpattanapipat, T Wang, CW Naisbitt, D Tassaneeyakul, W Ariyachaipanich, M Roonghiranwat, T Pirmohamed, M Chung, WH Sukasem, C |
2021 | ||||
| 168. | Meta-Analysis of Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations. | Khaeso, K Udayachalerm, S Komvilaisak, P Chainansamit, SO Suwannaying, K Laoaroon, N Kuwatjanakul, P Nakkam, N Sukasem, C Puangpetch, A Tassaneeyakul, W Chaiyakunapruk, N |
2021 | ||||
| 169. | Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations | Kanyarat Khaeso Sariya Udayachalerm Patcharee Komvilaisak Su-on Chainansamit Kunanya Suwannaying Napat Laoaroon Pitchayanan Kuwatjanakul Nontaya Nakkam Chonlaphat Sukasem Apichaya Puangpetch Wichittra Tassaneeyakul Nathorn Chaiyakunapruk |
2021 | ||||
| 170. | The Thai reference exome (T-REx) variant database | Shotelersuk, V Wichadakul, D Ngamphiw, C Srichomthong, C Phokaew, C Wilantho, A Pakchuen, S Nakhonsri, V Shaw, PJ Wasitthankasem, R Piriyapongsa, J Wangkumhang, P Assawapitaksakul, A Chetruengchai, W Lapphra, K Khuninthong, A Makarawate, P Suphapeetiporn, K Mahasirimongkol, S Satproedprai, N Porntaveetus, T Pisitkun, P Praphanphoj, V Kantaputra, P Tassaneeyakul, W Tongsima, S |
2021 | ||||
| 171. | Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. | Chuang-Wei Wang Wichittra Tassaneeyakul Chun-Bing Chen Wei-Ti Chen Yu-Chuan Teng Cheng-Yang Huang Chonlaphat Sukasem Chun-Wei Lu Yun-Shien Lee Siew-Eng Choon Nontaya Nakkam Rosaline Chung-Yee Hui Yen-Hua Huang Ya-Ching Chang Yang Yu-Wei Lin Chee-Jen Chang Tsu-Man Chiu Wasun Chantratita Parinya Konyoung Chaw-Ning Lee Jettanong Klaewsongkram Ticha Rerkpattanapipat Warayuwadee Amornpinyo Niwat Saksit Pawinee Rerknimitr Yu Huei Huang Shang-Hung Lin Chao-Kai Hsu Cheng-Chi Chan Yu- Lin Shuen-Iu Hung Wen-Hung Chung |
2021 | ||||
| 172. | Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions | Nakkam, N Saksit, N Konyoung, P Amornpinyo, W Khunarkornsiri, U Purimart, D Pattanacheewapull, O Naewla, T Wattanachai, P Khaeso, K Chumworathayi, P Tassaneeyakul, W |
2022 | ||||
| 173. | Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome. | Nakkam, N. Tassaneeyakul, W. Kaset, C. |
2022 | ||||
| 174. | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine. | Nakkam, N. Konyoung, P. Tiamkao, S. Khaeso, K. Jorns, T.P. Chumworathayi, P. Tassaneeyakul, W. |
2022 | ||||
| 175. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine | Khaeso, K Komvilaisak, P Chainansamit, SO Nakkam, N Suwannaying, K Kuwatjanakul, P Hikino, K Dornsena, A Kanjanawart, S Laoaroon, N Vannaprasaht, S Taketani, T Tassaneeyakul, W |
2022 | ||||
| 176. | Association between alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions. | Wattanachai, P Amornpinyo, W Konyoung, P Purimart, D Khunarkornsiri, U Pattanacheewapull, O Tassaneeyakul, W Nakkam, N |
2023 | ||||
| 177. | Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions | Wattanachai, P. Amornpinyo, W. Konyoung, P. Purimart, D. Khunarkornsiri, U. Pattanacheewapull, O. Tassaneeyakul, W. Nakkam, N. |
2023 | ||||
| 178. | Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand. | Kategeaw, W Nakkam, N Kiertiburanakul, S Sukasem, C Tassaneeyakul, W Chaiyakunapruk, N |
2023 | ||||
| 179. | Complete mitochondrial genomes of patients from Thailand with cardiovascular diseases | Woravatin, W Wongkomonched, R Tassaneeyakul, W Stoneking, M Makarawate, P Kutanan, W |
2024 | ||||
| 180. | Dual approaches in pharmacogenetics: Developing PCR-SSP and RT-PCR methods for HLA-B*13:01 screening to prevent dapsone and Co-trimoxazole SCARs. | Attapong, J Kaset, C Nakkam, N Tassaneeyakul, W Wichukchinda, N Chomean, S |
2024 | Count | 100 | 101 | 91 | 30 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Anti-inflammatory activity of 5,7-dimethoxyflavone | Panthong, A. Tassaneeyakul, W. Reutrakul, V. |
1989 |
Planta Medica 2 (55), pp. 133-136 |
||||||||
| 2. | Caffeine as a probe for human cytochromes p450: Validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques | Tassaneeyakul, W. McManus, M.E. |
1992 |
Pharmacogenetics 4 (2), pp. 173-183 |
||||||||
| 3. | Co-regulation of phenytoin and tolbutamide metabolism in humans | Tassaneeyakul, W. McManus, M.E. |
1992 |
British Journal of Clinical Pharmacology 6 (34), pp. 494-498 |
||||||||
| 4. | Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism | Tassaneeyakul, W. Tassaneeyakul, W. |
1993 |
British Journal of Clinical Pharmacology 6 (36), pp. 521-530 |
||||||||
| 5. | Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms | Tassaneeyakul, W. McManus, M.E. Tassaneeyakul, W. |
1994 |
Biochemical Pharmacology 10 (47), pp. 1767-1776 |
||||||||
| 6. | Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2 | Tassaneeyakul, W. McManus, M.E. |
1994 |
Pharmacogenetics 5 (4), pp. 281-284 |
||||||||
| 7. | Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 | Tassaneeyakul, W. Tassaneeyakul, W. |
1996 |
Journal of Pharmacology and Experimental Therapeutics 1 (276), pp. 101-108 |
||||||||
| 8. | Limited value of the urinary phenotyoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo | Tassaneeyakul, W. | 1996 |
British Journal of Clinical Pharmacology 6 (42), pp. 774-778 |
||||||||
| 9. | Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and nonsteroidal anti-inflammatory agents | Tassaneeyakul, W. | 1998 |
Xenobiotica 3 (28), pp. 293-301 |
||||||||
| 10. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice | Tassaneeyakul, W. Tassaneeyakul, W. Vannaprasaht, S. Yamazoe, Y. |
2000 |
British Journal of Clinical Pharmacology 2 (49), pp. 139-144 |
||||||||
| 11. | Inhibition selectivity of grapefruit juice components on human cytochromes P450 | Tassaneeyakul, W. Ohta, T. Yamazoe, Y. |
2000 |
Archives of Biochemistry and Biophysics 2 (378), pp. 356-363 |
||||||||
| 12. | Analysis of the CYP2C19 polymorphism in a North-eastern Thai population | Tassaneeyakul, W. Tawalee, A. Tassaneeyakul, W. Kukongviriyapan, V. Blaisdell, J.A. Goldstein, J.A. , |
2002 |
Pharmacogenetics 3 (12), pp. 221-225 |
||||||||
| 13. | Arylamine N-acetyltransferase-2 genotypes in the Thai population | Kukongviriyapan, V. Prawan, A. Tassaneyakul, W. Aiemsa-ard, J. Cushnie, B. |
2003 |
British Journal of Clinical Pharmacology 3 (55), pp. 278-281 |
||||||||
| 14. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] | Tassaneeyakul, W. Srimarthpirom, S. Reungjui, S. Chansung, G. Romphruk, A.V. Tassaneeyakul, W. |
2003 |
Transplantation 1 (76), pp. 265-266 |
||||||||
| 15. | Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population | Kukongviriyapan, V. Prawan, A. Cushnie, B. Tassaneyakul, W. Aiemsa-ard, J. |
2003 |
European Journal of Clinical Pharmacology 4 (59), pp. 277-281 |
||||||||
| 16. | Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand | Settheetham-Ishida, W. Singto, Y. Yuenyao, P. Tassaneeyakul, W. Kanjanavirojkul, N. Ishida, T. |
2004 |
Cancer Letters 2 (210), pp. 205-211 |
||||||||
| 17. | Thiopurine S-methyltransferase polymorphism in the Thai population | Tassaneeyakul, W. Kukongviriyapan, V. Tassaneeyakul, W. |
2004 |
British Journal of Clinical Pharmacology 1 (58), pp. 66-70 |
||||||||
| 18. | Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma | Prawan, A. Kukongviriyapan, V. Tassaneeyakul, W. Pairojkul, C. Bhudhisawasdi, V. |
2005 |
European Journal of Cancer Prevention 3 (14), pp. 245-250 |
||||||||
| 19. | Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines | Tepsiri, N.N. Chaturat, L. Sripa, B. Namwat, W. Wongkham, S. Bhudhisawasdi, V. Tassaneeyakul, W. |
2005 |
World Journal of Gastroenterology 18 (11), pp. 2748-2753 |
||||||||
| 20. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients | Tassaneeyakul, W. Kittiwattanagul, K. Vannaprasaht, S. Kampan, J. Tawalee, A. Puapairoj, P. Taimkao, S. Kukongviriyapan, V. Tassaneeyakul, W. |
2005 |
Journal of Pharmacy and Pharmaceutical Sciences 1 (8), pp. 47-53 |
||||||||
| 21. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. | Tassaneeyakul, W. Mahatthanatrakul, W. Niwatananun, K. Na-Bangchang, K. Tawalee, A. Krikreangsak, N. Cykleng, U. Tassaneeyakul, W. |
2006 |
Drug metabolism and pharmacokinetics 4 (21), pp. 286-290 |
||||||||
| 22. | Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6. | Satarug, S. Tassaneeyakul, W. Na-Bangchang, K. |
2006 |
Current clinical pharmacology 3 (1), pp. 291-309 |
||||||||
| 23. | Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 | Kukongviriyapan, V. Phromsopha, N. Tassaneeyakul, W. Kukongviriyapan, U. Sripa, B. Hahnvajanawong, V. Bhudhisawasdi, V. |
2006 |
Xenobiotica 1 (36), pp. 15-28 |
||||||||
| 24. | Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in Northeastern Thailand | Settheetham-Ishida, W. Yuenyao, P. Tassaneeyakul, W. Kanjanavirojkul, N. Thawmor, A. Kularbkaew, C. Hahvajanawong, C. Settheetham, D. Wattanathorn, J. Kashima, T. Ishida, T. |
2006 |
Asian Pacific Journal of Cancer Prevention 1 (7), pp. 113-118 |
||||||||
| 25. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis | Jitpimolmard, S. Sawanyawisuth, K. Morakote, N. Vejjajiva, A. Puntumetakul, M. Sanchaisuriya, K. Tassaneeyakul, W. Tassaneeyakul, W. |
2007 |
Parasitology Research 6 (100), pp. 1293-1296 |
||||||||
| 26. | Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients | Somparn, N. Kukongviriyapan, U. Tassaneeyakul, W. Jetsrisuparb, A. Kukongviriyapan, V. |
2007 |
European Journal of Clinical Pharmacology 1 (63), pp. 43-50 |
||||||||
| 27. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism | Boonsrirat, U. Angsuthum, S. Vannaprasaht, S. Kongpunvijit, J. Hirankarn, N. Tassaneeyakul, W. Avihingsanon, Y. |
2008 |
Lupus 2 (17), pp. 132-134 |
||||||||
| 28. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines | Namwat, N. Amimanan, P. Loilome, W. Jearanaikoon, P. Sripa, B. Bhudhisawasdi, V. Tassaneeyakul, W. |
2008 |
Chemotherapy 5 (54), pp. 343-351 |
||||||||
| 29. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers | Tassaneeyakul, W. Kanchanawat, S. Gaysonsiri, D. Vannaprasath, S. Paupairoj, P. Kittiwattanagul, K. Tippabhotla, S.K. Khuroo, A.H. Panigrahy, B.K. Reyar, S. Monif, T. |
2008 |
International Journal of Clinical Pharmacology and Therapeutics 3 (46), pp. 151-156 |
||||||||
| 30. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers | Tangsucharit, P. Kampan, J. Kanjanawart, S. Gaysonsiri, D. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Simasathiansophon, S. Puapairoj, P. Tassaneeyakul, W. |
2009 |
International Journal of Clinical Pharmacology and Therapeutics 10 (47), pp. 638-642 |
||||||||
| 31. | Cadmium exposure in thai populations from central, northern and northeastern thailand and the effects of food consumption on cadmium levels | Apinan, R. Satarug, S. Tassaneeyakul, W. Na-Bangchang, K. |
2009 |
Southeast Asian Journal of Tropical Medicine and Public Health 1 (40), pp. 177-186 |
||||||||
| 32. | CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking | Mahavorasirikul, W. Tassaneeyakul, W. Satarug, S. Reungweerayut, R. Na-Bangchang, C. Na-Bangchang, K. |
2009 |
European Journal of Clinical Pharmacology 4 (65), pp. 377-384 |
||||||||
| 33. | Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand | Vannaprasaht, S. Angsuthum, S. Avihingsanon, Y. Sirivongs, D. Pongskul, C. Makarawate, P. Tassaneeyakul, W. Tassaneeyakul, W. |
2009 |
Clinical Therapeutics 7 (31), pp. 1524-1533 |
||||||||
| 34. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Tassaneeyakul, W. Jantararoungtong, T. Tiamkao, S. Vannaprasaht, S. Choonhakarn, C. Pisuttimarn, P. Tassaneeyakul, W. |
2009 |
Pharmacogenetics and Genomics 9 (19), pp. 704-709 |
||||||||
| 35. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population | Apinan, R. Tassaneeyakul, W. Mahavorasirikul, W. Satarug, S. Vannaprasaht, S. Ruenweerayut, R. Na-Bangchang, K. |
2009 |
Environmental Toxicology and Pharmacology 3 (28), pp. 420-424 |
||||||||
| 36. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines | Hahnvajanawong, C. Boonyanugomol, W. Nasomyon, T. Loilome, W. Namwat, N. Anantachoke, N. Tassaneeyakul, W. Sripa, B. Namwat, W. Reutrakul, V. |
2010 |
World Journal of Gastroenterology 18 (16), pp. 2235-2243 |
||||||||
| 37. | Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population | Tassaneeyakul, W. Tiamkao, S. Jantararoungtong, T. Auvichayapat, N. Pavakul, K. Choonhakarn, C. Phonhiamhan, S. Piyatrakul, N. Aungaree, T. Pongpakdee, S. Yodnopaglaw, P. |
2010 |
Epilepsia 5 (51), pp. 926-930 |
||||||||
| 38. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration | Tassaneeyakul, W. Kumar, S.M. Gaysonsiri, D. Kaewkamson, T. Khuroo, A.H. Tangsucharit, P. Phunikhom, K. Vannaprasaht, S. Kanjanawart, S. Rao Thudi, N. Jain, R.K. Reyar, S. Monif, T. |
2010 |
International Journal of Clinical Pharmacology and Therapeutics 9 (48), pp. 614-620 |
||||||||
| 39. | Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin | Tassaneeyakul, W. Namchaisiri, J. |
2010 |
Drug Metabolism and Pharmacokinetics 6 (25), pp. 531-538 |
||||||||
| 40. | Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme | Feng, Q. Vannaprasaht, S. Angsuthum, S. Avihingsanon, Y. Tassaneeyakul, W. |
2010 |
Biochemical Pharmacology 7 (79), pp. 1053-1061 |
||||||||
| 41. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers | Kanjanawart, S. Gaysonsiri, D. Tangsucharit, P. Vannaprasaht, S. Phunikhom, K. Kaewkamson, T. Wattanachai, N. Tassaneeyakul, W. |
2011 |
International Journal of Clinical Pharmacology and Therapeutics 8 (49), pp. 525-530 |
||||||||
| 42. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | Namwat, N. Puetkasichonpasutha, J. Loilome, W. Yongvanit, P. Techasen, A. Puapairoj, A. Sripa, B. Tassaneeyakul, W. Khuntikeo, N. Wongkham, S. |
2011 |
Journal of Gastroenterology 5 (46), pp. 664-675 |
||||||||
| 43. | Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines | Hahnvajanawong, C. Ketnimit, S. Boonyanugomol, W. Chamgramol, Y. Sripa, B. Namwat, N. Pinmai, K. Tassaneeyakul, W. Reutrakul, V. |
2011 |
Asian Biomedicine 6 (5), pp. 775-785 |
||||||||
| 44. | Inhibitory effects of phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: Evidence for CYP3A4 mechanism-based Inhibition | Taesotikul, T. Dumrongsakulchai, W. Wattanachai, N. Tassaneeyakul, W. Tassaneeyakul, W. |
2011 |
Drug Metabolism and Pharmacokinetics 2 (26), pp. 154-161 |
||||||||
| 45. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Wattanachai, N. Uchaipichat, V. Tassaneeyakul, W. Tassaneeyakul, W. |
2011 |
European Journal of Clinical Pharmacology 8 (67), pp. 815-824 |
||||||||
| 46. | Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: Impact on in vitro-in vivo extrapolation of drug clearance | Wattanachai, N. Tassaneeyakul, W. |
2012 |
Drug Metabolism and Disposition 5 (40), pp. 982-989 |
||||||||
| 47. | Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats | Taesotikul, T. Tassaneeyakul, W. |
2012 |
Xenobiotica 7 (42), pp. 641-648 |
||||||||
| 48. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma | Yongvanit, P. Phanomsri, E. Namwat, N. Kampan, J. Tassaneeyakul, W. Loilome, W. Puapairoj, A. Khuntikeo, N. |
2012 |
Parasitology International 1 (61), pp. 162-166 |
||||||||
| 49. | High Expression of ABCC1 Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma | Srimunta, U. Sawanyawisuth, K. Kraiklang, R. Pairojkul, C. Puapairoj, A. Titipungul, T. Hahnvajanawong, C. Tassaneeyakul, W. Wongkham, C. Wongkham, S. Vaeteewoottacharn, K. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 125-130 |
||||||||
| 50. | HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain | Tassaneeyakul, W. Tiamkao, S. Jantararoungtong, T. Prabmechai, N. Vannaprasaht, S. Chumworathayi, P. |
2012 |
Pain Practice 3 (12), pp. 202-208 |
||||||||
| 51. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil | Hahnvajanawong, C. Chaiyagool, J. Seubwai, W. Bhudhisawasdi, V. Namwat, N. Khuntikeo, N. Sripa, B. Pugkhem, A. Tassaneeyakul, W. |
2012 |
World Journal of Gastroenterology 30 (18), pp. 3955-3961 |
||||||||
| 52. | Suppression of PRKAR1A expression enhances antiproliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma Cells | Loilome, W. Juntana, S. Pinitsoontorn, C. Namwat, N. Tassaneeyakul, W. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 143-147 |
||||||||
| 53. | Clinical pharmacogenetics implementation consortium guidelines for human leukocyte antigen-b genotype and allopurinol dosing | Callaghan, J.T. Tassaneeyakul, W. Lee, M.T.M. |
2013 |
Clinical Pharmacology and Therapeutics 2 (93), pp. 153-158 |
||||||||
| 54. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers | Kanjanawart, S. Gaysonsiri, D. Phunikom, K. Tangsucharit, P. Vannaprasaht, S. Kaewkamson, T. Tassaneeyakul, W. |
2013 |
International Journal of Clinical Pharmacology and Therapeutics 3 (51), pp. 249-254 |
||||||||
| 55. | Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation | Vannaprasaht, S. Reungjui, S. Supanya, D. Sirivongs, D. Pongskul, C. Avihingsanon, Y. Tassaneeyakul, W. |
2013 |
Clinical Therapeutics 11 (35), pp. 1762-1769 |
||||||||
| 56. | Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis | Chaiyakunapruk, N. Tassaneeyakul, W. |
2013 |
JAMA Dermatology 9 (149), pp. 1025-1032 |
||||||||
| 57. | Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy | Auvichayapat, N. Rotenberg, A. Gersner, R. Ngodklang, S. Tiamkao, S. Tassaneeyakul, W. Auvichayapat, P. |
2013 |
Brain Stimulation 4 (6), pp. 696-700 |
||||||||
| 58. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Tassaneeyakul, W. Sawanyawisuth, K. |
2014 |
Singapore Medical Journal 4 (55), pp. 217-220 |
||||||||
| 59. | Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population | Tassaneeyakul, W. Maenthaisong, R. Chaiyakunapruk, N. |
2014 |
PLoS ONE 4 (9), pp. |
||||||||
| 60. | High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis | Thongchot, S. Yongvanit, P. Loilome, W. Seubwai, W. Phunicom, K. Tassaneeyakul, W. Pairojkul, C. Promkotra, W. Techasen, A. Namwat, N. |
2014 |
Asian Pacific Journal of Cancer Prevention 14 (15), pp. 5873-5878 |
||||||||
| 61. | Outcomes of symptomatic Brugada syndrome patients with implanted cardioverter defibrillators: A report from an endemic area | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Tassaneeyakul, W. Sawanyawisuth, K. |
2014 |
Journal of Arrhythmia 1 (30), pp. 55-57 |
||||||||
| 62. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jongthawin, J. Chusorn, P. Techasen, A. Loilome, W. Boonmars, T. Thanan, R. Puapairoj, A. Khuntikeo, N. Tassaneeyakul, W. Yongvanit, P. Namwat, N. |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 8 (35), pp. 8051-8064 |
||||||||
| 63. | Pharmacogenomics of drug-induced hypersensitivity reactions: Challenges, opportunities and clinical implementation | Puangpetch, A. Tassaneeyakul, W. |
2014 |
Asian Pacific Journal of Allergy and Immunology 2 (32), pp. 111-123 |
||||||||
| 64. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions | Kongpan, T. Mahasirimongkol, S. Kanjanawart, S. Chumworathayi, P. Mootsikapun, P. Vannaprasaht, S. Tassaneayakul, W. Tassaneeyakul, W. |
2015 |
Pharmacogenetics and Genomics 8 (25), pp. 402-411 |
||||||||
| 65. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions | Nakkam, N. Tiamkao, S. Kanjanawart, S. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2015 |
Drug Metabolism and Pharmacokinetics 4 (30), pp. 295-304 |
||||||||
| 66. | Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Kongpan, T. Chumworathayi, P. Tiamkao, S. Nakkam, N. Vannaprasaht, S. Mahasirimongkol, S. Tassaneeyakul, W. |
2016 |
Pharmacogenetics and Genomics 5 (26), pp. 225-234 |
||||||||
| 67. | CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network | Callaghan, J.T. Tassaneeyakul, W. Lee, M.T.M. |
2016 |
Clinical Pharmacology and Therapeutics 1 (99), pp. 36-37 |
||||||||
| 68. | Association of HLA-A and HLA-B alleles with lamotrigine-induced cutaneous adverse drug reactions in the Thai population | Jantararoungtong, T. Tassaneeyakul, W. Puangpetch, A. |
2017 |
Frontiers in Pharmacology NOV (8), pp. |
||||||||
| 69. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Tassaneeyakul, W. Nakkam, N. Tiamkao, S. Kanjanawart, S. Phunikhom, K. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 |
International Journal of Clinical Pharmacology and Therapeutics 2 (55), pp. 177-185 |
||||||||
| 70. | Comparison between the HLA-B ∗ 58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions | Nakkam, N Chumworathayi, P. Kanjanawart, S. Tassaneeyakul, W. |
2017 |
Journal of Immunology Research (2017), pp. |
||||||||
| 71. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population | Nakkam, N. Wattanakrai, P. Jantararoungtong, T. Mahakkanukrauh, A. Tassaneeyakul, W. |
2017 |
Pharmacogenetics and Genomics 12 (27), pp. 429-437 |
||||||||
| 72. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance | Namwat, N. Yongvanit, P. Loilome, W. Khuntikeo, N. Tassaneeyakul, W. Tangsucharit, P. Yothaisong, S. |
2017 |
Parasitology International 4 (66), pp. 471-478 |
||||||||
| 73. | Outcomes of a randomized controlled trial comparing modified high dose omeprazole and amoxicillin triple therapy with standard triple therapy for helicobacter pylori eradication | Mairiang, P. Vannaprasaht, S. Tassaneeyakul, W. Sangchan, A. Sawadpanich, K. |
2017 |
Asian Pacific Journal of Cancer Prevention 4 (18), pp. 927-932 |
||||||||
| 74. | Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians | Tassaneeyakul, W. Jorns, T.P. |
2017 |
Neurology 1 (88), pp. 78-86 |
||||||||
| 75. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Nakkam, N. Chumworathayi, P. Chaiyakunapruk, N. Sawanyawisuth, K.I. Tassaneeyakul, W. |
2017 |
Pharmacogenetics and Genomics 7 (27), pp. 255-263 |
||||||||
| 76. | SCN5A genetic polymorphisms associated with increased defibrillator shocks in Brugada syndrome | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Sahasthas, D. Tassaneeyakul, W. Sawanyawisuth, K.I. |
2017 |
Journal of the American Heart Association 6 (6), pp. |
||||||||
| 77. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients | Wattanachai, N. Pussadhamma, B. Makarawate, P. Wongvipaporn, C. Kiatchoosakun, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 |
European Journal of Clinical Pharmacology 8 (73), pp. 973-980 |
||||||||
| 78. | Cost-effectiveness analysis of HLA-B ∗ 58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population | Tassaneeyakul, W. Chaiyakunapruk, N. |
2018 |
Pharmacogenetics and Genomics 2 (28), pp. 56-67 |
||||||||
| 79. | Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia | Tassaneeyakul, W. | 2018 |
Free Radical Research 4 (52), pp. 415-425 |
||||||||
| 80. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 |
Frontiers in Genetics AUG (9), pp. |
||||||||
| 81. | New advances in drug hypersensitivity research and treatment | Chung, W.H. Tassaneeyakul, W. |
2018 |
Journal of Immunology Research (2018), pp. |
||||||||
| 82. | HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians | Nakkam, N | 2019 |
Clinical Pharmacology and Therapeutics 2 (105), pp. 476-485 |
||||||||
| 83. | Identification of drug-specific public TCR driving severe cutaneous adverse reactions | Pan, R.Y. Tassaneeyakul, W. Chung, W.H. |
2019 |
Nature Communications 1 (10), pp. |
||||||||
| 84. | Long term stability of immunophenotypic T cell subsets from whole blood of tacrolimus-based therapy kidney transplantation patients and healthy volunteers by flow cytometric analysis | Wongratanacheewin, S. Kaewraemruaen, C. Vannaprasaht, S. |
2019 |
Asia-Pacific Journal of Science and Technology 3 (24), pp. |
||||||||
| 85. | Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect | Chaiyakunapruk, N. Tassaneeyakul, W. Arunmanakul, P. Nathisuwan, S. |
2019 |
International Journal of Cardiology (280), pp. 190-197 |
||||||||
| 86. | The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label | Nakkam, N | 2019 |
Clinical Pharmacology and Therapeutics 1 (105), pp. 112-120 |
||||||||
| 87. | Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes | Puangpetch, A. Nakkam, N. Kanjanawart, S. Kongpan, T. Chumworathayi, P. Tassaneeyakul, W. Chantràtita, W. |
2020 |
Clinical Pharmacology and Therapeutics 5 (108), pp. 1078-1089 |
||||||||
| 88. | Prevalence of CYP2C19, CYP3A4 and FMO3 genetic polymorphisms in healthy northeastern Thai volunteers | Kanjanawart, S. Nakkam, N. Tassaneeyakul, W. |
2020 |
ScienceAsia 4 (46), pp. 397-402 |
||||||||
| 89. | Protective effects of purple waxy corn on aflatoxin B1-induced oxidative stress and micronucleus in HepG2 cells | Tassaneeyakul, W. Porasuphatana, S. |
2020 |
Indian Journal of Pharmaceutical Sciences 3 (82), pp. 506-513 |
||||||||
| 90. | Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01 | Tassaneeyakul, W. Nakkam, N. |
2021 |
Frontiers in Immunology (12), pp. |
||||||||
| 91. | HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Nakkam, N. Mahakkanukrauh, A. Jantararoungtong, T. Tassaneeyakul, W. |
2021 |
Frontiers in Immunology (12), pp. |
||||||||
| 92. | Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations | Khaeso, K. Komvilaisak, P. Chainansamit, S.O. Nakkam, N. Puangpetch, A. Tassaneeyakul, W. Chaiyakunapruk, N. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
| 93. | The Thai reference exome (T-REx) variant database | Phokaew, C. Wasitthankasem, R. Makarawate, P. Suphapeetiporn, K. Mahasirimongkol, S. Pisitkun, P. Tassaneeyakul, W. |
2021 |
Clinical Genetics 6 (100), pp. 703-712 |
||||||||
| 94. | Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians | Tassaneeyakul, W. Nakkam, N. Chantràtita, W. |
2021 |
Journal of Allergy and Clinical Immunology 4 (147), pp. 1402-1412 |
||||||||
| 95. | Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions | Nakkam, N. Saksit, N. Konyoung, P. Amornpinyo, W. Khunarkornsiri, U. Purimart, D. Pattanacheewapull, O. Naewla, T. Wattanachai, P. Khaeso, K. Chumworathayi, P. Tassaneeyakul, W. |
2022 |
Drug Metabolism and Pharmacokinetics (47), pp. |
||||||||
| 96. | Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome | Nakkam, N. Tassaneeyakul, W. Kaset, C. |
2022 |
Analytical Biochemistry (658), pp. |
||||||||
| 97. | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine | Nakkam, N. Konyoung, P. Tiamkao, S. Khaeso, K. Jorns, T.P. Chumworathayi, P. Tassaneeyakul, W. |
2022 |
British Journal of Clinical Pharmacology 2 (88), pp. 773-786 |
||||||||
| 98. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine | Khaeso, K. Komvilaisak, P. Chainansamit, S.O. Nakkam, N. Kanjanawart, S. Vannaprasaht, S. Tassaneeyakul, W. |
2022 |
Drug Metabolism and Pharmacokinetics (43), pp. |
||||||||
| 99. | Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions | Wattanachai, P. Amornpinyo, W. Konyoung, P. Purimart, D. Khunarkornsiri, U. Pattanacheewapull, O. Tassaneeyakul, W. Nakkam, N. |
2023 |
Frontiers in Pharmacology (14), pp. |
||||||||
| 100. | Complete mitochondrial genomes of patients from Thailand with cardiovascular diseases | Woravatin, W. Wongkomonched, R. Tassaneeyakul, W. |
2024 |
PLoS ONE 7 July (19), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column. | Lambert, WE de Leenheer, AP Walgraeve, HR Tassaneeyakul, W |
1988 |
Journal of chromatography 1 (427), pp. 195-8 |
|
| 2. | Anti-inflammatory activity of 5,7-dimethoxyflavone. | Panthong, A Tassaneeyakul, W Kanjanapothi, D Tantiwachwuttikul, P Reutrakul, V |
1989 |
Planta medica 2 (55), pp. 133-6 |
|
| 3. | Co-regulation of phenytoin and tolbutamide metabolism in humans. | Tassaneeyakul, W Veronese, ME Birkett, DJ Doecke, CJ McManus, ME Sansom, LN Miners, JO |
1992 |
British journal of clinical pharmacology 6 (34), pp. 494-8 |
|
| 4. | Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. | Tassaneeyakul, W Mohamed, Z Birkett, DJ McManus, ME Veronese, ME Tukey, RH Quattrochi, LC Gonzalez, FJ Miners, JO |
1992 |
Pharmacogenetics 4 (2), pp. 173-83 |
|
| 5. | A study of major causes and types of poisoning in Khonkaen, Thailand. | Chirasirisap, K Ussanawarong, S Tassaneeyakul, W Reungsritrakool, W Prasitwatanaseree, W Sripanyawit, U Premkamol, A Prasartthong, W Patitas, N |
1992 |
Veterinary and human toxicology 6 (34), pp. 489-92 |
|
| 6. | High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes. | Tassaneeyakul, W Veronese, ME Birkett, DJ Miners, JO |
1993 |
Journal of chromatography 1 (616), pp. 73-8 |
|
| 7. | Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. | Andersson, T Miners, JO Veronese, ME Tassaneeyakul, W Meyer, UA Birkett, DJ |
1993 |
British journal of clinical pharmacology 6 (36), pp. 521-30 |
|
| 8. | Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. | Tassaneeyakul, W Birkett, DJ Veronese, ME McManus, ME Tukey, RH Quattrochi, LC Gelboin, HV Miners, JO |
1993 |
The Journal of pharmacology and experimental therapeutics 1 (265), pp. 401-7 |
|
| 9. | Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. | Tassaneeyakul, W Veronese, ME Birkett, DJ Gonzalez, FJ Miners, JO |
1993 |
Biochemical pharmacology 11 (46), pp. 1975-81 |
|
| 10. | Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. | Tassaneeyakul, W Birkett, DJ McManus, ME Veronese, ME Andersson, T Tukey, RH Miners, JO |
1994 |
Biochemical pharmacology 10 (47), pp. 1767-76 |
|
| 11. | Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2. | Tassaneeyakul, W Birkett, DJ Veronese, ME McManus, ME Tukey, RH Miners, JO |
1994 |
Pharmacogenetics 5 (4), pp. 281-4 |
|
| 12. | Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo. | Tassaneeyakul, W Birkett, DJ Pass, MC Miners, JO |
1996 |
British journal of clinical pharmacology 6 (42), pp. 774-8 |
|
| 13. | Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. | Tassaneeyakul, W Birkett, DJ Edwards, JW Veronese, ME Tukey, RH Miners, JO |
1996 |
The Journal of pharmacology and experimental therapeutics 1 (276), pp. 101-8 |
|
| 14. | Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and non-steroidal anti-inflammatory agents. | Tassaneeyakul, W Birkett, DJ Miners, JO |
1998 |
Xenobiotica; the fate of foreign compounds in biological systems 3 (28), pp. 293-301 |
|
| 15. | Inhibition selectivity of grapefruit juice components on human cytochromes P450. | Tassaneeyakul, W Guo, LQ Fukuda, K Ohta, T Yamazoe, Y |
2000 |
Archives of biochemistry and biophysics 2 (378), pp. 356-63 |
|
| 16. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. | Tassaneeyakul, W Vannaprasaht, S Yamazoe, Y |
2000 |
British journal of clinical pharmacology 2 (49), pp. 139-44 |
|
| 17. | Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. | Tassaneeyakul, W Tawalee, A Tassaneeyakul, W Kukongviriyapan, V Blaisdell, J Goldstein, JA Gaysornsiri, D |
2002 |
Pharmacogenetics 3 (12), pp. 221-5 |
|
| 18. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. | Tassaneeyakul, W Srimarthpirom, S Reungjui, S Chansung, K Romphruk, A Tassaneeyakul, W |
2003 |
Transplantation 1 (76), pp. 265-6 |
|
| 19. | Arylamine N-acetyltransferase-2 genotypes in the Thai population. | Kukongviriyapan, V Prawan, A Tassaneyakul, W Aiemsa-Ard, J Warasiha, B |
2003 |
British journal of clinical pharmacology 3 (55), pp. 278-81 |
|
| 20. | Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population. | Kukongviriyapan, V Prawan, A Warasiha, B Tassaneyakul, W Aiemsa-ard, J |
2003 |
European journal of clinical pharmacology 4 (59), pp. 277-81 |
|
| 21. | Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand. | Settheetham-Ishida, W Singto, Y Yuenyao, P Tassaneeyakul, W Kanjanavirojkul, N Ishida, T |
2004 |
Cancer letters 2 (210), pp. 205-11 |
|
| 22. | Thiopurine S-methyltransferase genetic polymorphism in the Thai population. | Srimartpirom, S Tassaneeyakul, W Kukongviriyapan, V Tassaneeyakul, W |
2004 |
British journal of clinical pharmacology 1 (58), pp. 66-70 |
|
| 23. | Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. | Tepsiri, N Chaturat, L Sripa, B Namwat, W Wongkham, S Bhudhisawasdi, V Tassaneeyakul, W |
2005 |
World journal of gastroenterology : WJG 18 (11), pp. 2748-53 |
|
| 24. | Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma. | Prawan, A Kukongviriyapan, V Tassaneeyakul, W Pairojkul, C Bhudhisawasdi, V |
2005 |
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 3 (14), pp. 245-50 |
|
| 25. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. | Tassaneeyakul, W Kittiwattanagul, K Vannaprasaht, S Kampan, J Tawalee, A Puapairoj, P Tiamkao, S Juthagridsada, S Kukongviriyapan, V Tassaneeyakul, W |
2005 |
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 1 (8), pp. 47-53 |
|
| 26. | Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2. | Kukongviriyapan, V Phromsopha, N Tassaneeyakul, W Kukongviriyapan, U Sripa, B Hahnvajanawong, V Bhudhisawasdi, V |
2006 |
Xenobiotica; the fate of foreign compounds in biological systems 1 (36), pp. 15-28 |
|
| 27. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. | Tassaneeyakul, W Mahatthanatrakul, W Niwatananun, K Na-Bangchang, K Tawalee, A Krikreangsak, N Cykleng, U Tassaneeyakul, W |
2006 |
Drug metabolism and pharmacokinetics 4 (21), pp. 286-90 |
|
| 28. | Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6. | Satarug, S Tassaneeyakul, W Na-Bangchang, K Cashman, JR Moore, MR |
2006 |
Current clinical pharmacology 3 (1), pp. 291-309 |
|
| 29. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. | Jitpimolmard, S Sawanyawisuth, K Morakote, N Vejjajiva, A Puntumetakul, M Sanchaisuriya, K Tassaneeyakul, W Tassaneeyakul, W Korwanich, N |
2007 |
Parasitology research 6 (100), pp. 1293-6 |
|
| 30. | Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. | Somparn, N Kukongviriyapan, U Tassaneeyakul, W Jetsrisuparb, A Kukongviriyapan, V |
2007 |
European journal of clinical pharmacology 1 (63), pp. 43-50 |
|
| 31. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers. | Tassaneeyakul, W Kanchanawat, S Gaysonsiri, D Vannaprasath, S Paupairoj, P Kittiwattanagul, K Tippabhotla, SK Khuroo, A Panigrahy, BK Reyar, S Monif, T |
2008 |
International journal of clinical pharmacology and therapeutics 3 (46), pp. 151-6 |
|
| 32. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. | Boonsrirat, U Angsuthum, S Vannaprasaht, S Kongpunvijit, J Hirankarn, N Tassaneeyakul, W Avihingsanon, Y |
2008 |
Lupus 2 (17), pp. 132-4 |
|
| 33. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. | Namwat, N Amimanan, P Loilome, W Jearanaikoon, P Sripa, B Bhudhisawasdi, V Tassaneeyakul, W |
2008 |
Chemotherapy 5 (54), pp. 343-51 |
|
| 34. | CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking. | Mahavorasirikul, W Tassaneeyakul, W Satarug, S Reungweerayut, R Na-Bangchang, C Na-Bangchang, K |
2009 |
European journal of clinical pharmacology 4 (65), pp. 377-84 |
|
| 35. | Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. | Vannaprasaht, S Angsuthum, S Avihingsanon, Y Sirivongs, D Pongskul, C Makarawate, P Praditpornsilpa, K Tassaneeyakul, W Tassaneeyakul, W |
2009 |
Clinical therapeutics 7 (31), pp. 1524-33 |
|
| 36. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. | Tassaneeyakul, W Jantararoungtong, T Chen, P Lin, PY Tiamkao, S Khunarkornsiri, U Chucherd, P Konyoung, P Vannaprasaht, S Choonhakarn, C Pisuttimarn, P Sangviroon, A Tassaneeyakul, W |
2009 |
Pharmacogenetics and genomics 9 (19), pp. 704-9 |
|
| 37. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers. | Tangsucharit, P Kampan, J Kanjanawart, S Gaysonsiri, D Vannaprasaht, S Tiamkao, S Phunikhom, K Simasathiansophon, S Puapairoj, P Tassaneeyakul, W |
2009 |
International journal of clinical pharmacology and therapeutics 10 (47), pp. 638-42 |
|
| 38. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population. | Apinan, R Tassaneeyakul, W Mahavorasirikul, W Satarug, S Kajanawart, S Vannaprasaht, S Ruenweerayut, R Na-Bangchang, K |
2009 |
Environmental toxicology and pharmacology 3 (28), pp. 420-4 |
|
| 39. | Cadmium exposure in Thai populations from central, northern and northeastern Thailand and the effects of food consumption on cadmium levels. | Apinan, R Satarug, S Ruengweerayut, R Tassaneeyakul, W Na-Bangchang, K |
2009 |
The Southeast Asian journal of tropical medicine and public health 1 (40), pp. 177-86 |
|
| 40. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration. | Tassaneeyakul, W Kumar, S Gaysonsiri, D Kaewkamson, T Khuroo, A Tangsucharit, P Phunikhom, K Vannaprasaht, S Kanjanawart, S Rao Thudi, N Jain, R Reyar, S Monif, T |
2010 |
International journal of clinical pharmacology and therapeutics 9 (48), pp. 614-20 |
|
| 41. | Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. | Tassaneeyakul, W Tiamkao, S Jantararoungtong, T Chen, P Lin, SY Chen, WH Konyoung, P Khunarkornsiri, U Auvichayapat, N Pavakul, K Kulkantrakorn, K Choonhakarn, C Phonhiamhan, S Piyatrakul, N Aungaree, T Pongpakdee, S Yodnopaglaw, P |
2010 |
Epilepsia 5 (51), pp. 926-30 |
|
| 42. | Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin. | Sangviroon, A Panomvana, D Tassaneeyakul, W Namchaisiri, J |
2010 |
Drug metabolism and pharmacokinetics 6 (25), pp. 531-8 |
|
| 43. | Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme. | Feng, Q Vannaprasaht, S Peng, Y Angsuthum, S Avihingsanon, Y Yee, VC Tassaneeyakul, W Weinshilboum, RM |
2010 |
Biochemical pharmacology 7 (79), pp. 1053-61 |
|
| 44. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. | Hahnvajanawong, C Boonyanugomol, W Nasomyon, T Loilome, W Namwat, N Anantachoke, N Tassaneeyakul, W Sripa, B Namwat, W Reutrakul, V |
2010 |
World journal of gastroenterology : WJG 18 (16), pp. 2235-43 |
|
| 45. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. | Namwat, N Puetkasichonpasutha, J Loilome, W Yongvanit, P Techasen, A Puapairoj, A Sripa, B Tassaneeyakul, W Khuntikeo, N Wongkham, S |
2011 |
Journal of gastroenterology 5 (46), pp. 664-75 |
|
| 46. | Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. | Taesotikul, T Dumrongsakulchai, W Wattanachai, N Navinpipat, V Somanabandhu, A Tassaneeyakul, W Tassaneeyakul, W |
2011 |
Drug metabolism and pharmacokinetics 2 (26), pp. 154-61 |
|
| 47. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. | Wattanachai, N Polasek, TM Heath, TM Uchaipichat, V Tassaneeyakul, W Tassaneeyakul, W Miners, JO |
2011 |
European journal of clinical pharmacology 8 (67), pp. 815-24 |
|
| 48. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers. | Kanjanawart, S Gaysonsiri, D Tangsucharit, P Vannaprasaht, S Phunikhom, K Kaewkamson, T Wattanachai, N Tassaneeyakul, W |
2011 |
International journal of clinical pharmacology and therapeutics 8 (49), pp. 525-30 |
|
| 49. | Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance. | Wattanachai, N Tassaneeyakul, W Rowland, A Elliot, DJ Bowalgaha, K Knights, KM Miners, JO |
2012 |
Drug metabolism and disposition: the biological fate of chemicals 5 (40), pp. 982-9 |
|
| 50. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. | Hahnvajanawong, C Chaiyagool, J Seubwai, W Bhudhisawasdi, V Namwat, N Khuntikeo, N Sripa, B Pugkhem, A Tassaneeyakul, W |
2012 |
World journal of gastroenterology : WJG 30 (18), pp. 3955-61 |
|
| 51. | Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats. | Taesotikul, T Nakajima, M Tassaneeyakul, W Yokoi, T |
2012 |
Xenobiotica; the fate of foreign compounds in biological systems 7 (42), pp. 641-8 |
|
| 52. | Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. | Loilome, W Juntana, S Pinitsoontorn, C Namwat, N Tassaneeyakul, W Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 143-7 |
|
| 53. | High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma. | Srimunta, U Sawanyawisuth, K Kraiklang, R Pairojkul, C Puapairoj, A Titipungul, T Hahnvajanawong, C Tassaneeyakul, W Wongkham, C Wongkham, S Vaeteewoottacharn, K |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 125-30 |
|
| 54. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. | Yongvanit, P Phanomsri, E Namwat, N Kampan, J Tassaneeyakul, W Loilome, W Puapairoj, A Khuntikeo, N |
2012 |
Parasitology international 1 (61), pp. 162-6 |
|
| 55. | HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. | Kulkantrakorn, K Tassaneeyakul, W Tiamkao, S Jantararoungtong, T Prabmechai, N Vannaprasaht, S Chumworathayi, P Chen, P Sritipsukho, P |
2012 |
Pain practice : the official journal of World Institute of Pain 3 (12), pp. 202-8 |
|
| 56. | Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. | Tangamornsuksan, W Chaiyakunapruk, N Somkrua, R Lohitnavy, M Tassaneeyakul, W |
2013 |
JAMA dermatology 9 (149), pp. 1025-32 |
|
| 57. | Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. | Hershfield, MS Callaghan, JT Tassaneeyakul, W Mushiroda, T Thorn, CF Klein, TE Lee, MT |
2013 |
Clinical pharmacology and therapeutics 2 (93), pp. 153-8 |
|
| 58. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers. | Kanjanawart, S Gaysonsiri, D Phunikom, K Simasathiansopon, S Tangsucharit, P Vannaprasaht, S Kaewkamson, T Tassaneeyakul, W |
2013 |
International journal of clinical pharmacology and therapeutics 3 (51), pp. 249-54 |
|
| 59. | Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy. | Auvichayapat, N Rotenberg, A Gersner, R Ngodklang, S Tiamkao, S Tassaneeyakul, W Auvichayapat, P |
2013 |
Brain stimulation 4 (6), pp. 696-700 |
|
| 60. | Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. | Vannaprasaht, S Reungjui, S Supanya, D Sirivongs, D Pongskul, C Avihingsanon, Y Tassaneeyakul, W |
2013 |
Clinical therapeutics 11 (35), pp. 1762-9 |
|
| 61. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand. | Makarawate, P Chaosuwannakit, N Vannaprasaht, S Tassaneeyakul, W Sawanyawisuth, K |
2014 |
Singapore medical journal 4 (55), pp. 217-20 |
|
| 62. | Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation. | Sukasem, C Puangpetch, A Medhasi, S Tassaneeyakul, W |
2014 |
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2 (32), pp. 111-23 |
|
| 63. | Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population. | Saokaew, S Tassaneeyakul, W Maenthaisong, R Chaiyakunapruk, N |
2014 |
PloS one 4 (9), pp. e94294 |
|
| 64. | High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. | Thongchot, S Yongvanit, P Loilome, W Seubwai, W Phunicom, K Tassaneeyakul, W Pairojkul, C Promkotra, W Techasen, A Namwat, N |
2014 |
Asian Pacific journal of cancer prevention : APJCP 14 (15), pp. 5873-8 |
|
| 65. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. | Jongthawin, J Chusorn, P Techasen, A Loilome, W Boonmars, T Thanan, R Puapairoj, A Khuntikeo, N Tassaneeyakul, W Yongvanit, P Namwat, N |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 8 (35), pp. 8051-64 |
|
| 66. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. | Kongpan, T Mahasirimongkol, S Konyoung, P Kanjanawart, S Chumworathayi, P Wichukchinda, N Kidkeukarun, R Preechakul, S Khunarkornsiri, U Bamrungram, W Supharatwattanakun, B Mootsikapun, P Kwangsukstid, S Denjanta, S Vannaprasaht, S Rungapiromnan, W Suwankesawong, W Tassaneeyakul, W Tassaneeyakul, W |
2015 |
Pharmacogenetics and genomics 8 (25), pp. 402-11 |
|
| 67. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. | Nakkam, N Tiamkao, S Kanjanawart, S Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2015 |
Drug metabolism and pharmacokinetics 4 (30), pp. 295-304 |
|
| 68. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. | Tassaneeyakul, W Prabmeechai, N Sukasem, C Kongpan, T Konyoung, P Chumworathayi, P Tiamkao, S Khunarkornsiri, U Kulkantrakorn, K Saksit, N Nakkam, N Satapornpong, P Vannaprasaht, S Sangviroon, A Mahasirimongkol, S Wichukchinda, N Rerkpattanapipat, T Tassaneeyakul, W |
2016 |
Pharmacogenetics and genomics 5 (26), pp. 225-34 |
|
| 69. | Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. | Saito, Y Stamp, LK Caudle, KE Hershfield, MS McDonagh, EM Callaghan, JT Tassaneeyakul, W Mushiroda, T Kamatani, N Goldspiel, BR Phillips, EJ Klein, TE Lee, M |
2016 |
Clinical pharmacology and therapeutics 1 (99), pp. 36-7 |
|
| 70. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers . | Nakkam, N Tiamkao, S Kanjanawart, S Phunikhom, K Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2017 |
International journal of clinical pharmacology and therapeutics 2 (55), pp. 177-185 |
|
| 71. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. | Yothaisong, S Namwat, N Yongvanit, P Khuntikeo, N Puapairoj, A Jutabha, P Anzai, N Tassaneeyakul, W Tangsucharit, P Loilome, W |
2017 |
Parasitology international 4 (66), pp. 471-478 |
|
| 72. | Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. | Chen, CB Hsiao, YH Wu, T Hsih, MS Tassaneeyakul, W Jorns, TP Sukasem, C Hsu, CN Su, SC Chang, WC Hui, RC Chu, CY Chen, YJ Wu, CY Hsu, CK Chiu, TM Sun, PL Lee, HE Yang, CY Kao, PH Yang, CH Ho, HC Lin, JY Chang, YC Chen, MJ Lu, CW Ng, CY Kuo, KL Lin, CY Yang, CS Chen, DP Chang, PY Wu, TL Lin, YJ Weng, YC Kuo, TT Hung, SI Chung, WH , |
2017 |
Neurology 1 (88), pp. 78-86 |
|
| 73. | Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication | Chunlertlith, K Limpapanasit, U Mairiang, P Vannaprasaht, S Tassaneeyakul, W Sangchan, A Sawadpanich, K Suttichaimongkol, T Pongpit, J Pattarapongsin, M |
2017 |
Asian Pacific journal of cancer prevention : APJCP 4 (18), pp. 927-932 |
|
| 74. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. | Saksit, N Tassaneeyakul, W Nakkam, N Konyoung, P Khunarkornsiri, U Chumworathayi, P Sukasem, C Suttisai, S Piriyachananusorn, N Tiwong, P Chaiyakunapruk, N Sawanyawisuth, K Rerkpattanapipat, T Tassaneeyakul, W |
2017 |
Pharmacogenetics and genomics 7 (27), pp. 255-263 |
|
| 75. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients. | Wattanachai, N Kaewmoongkun, S Pussadhamma, B Makarawate, P Wongvipaporn, C Kiatchoosakun, S Vannaprasaht, S Tassaneeyakul, W |
2017 |
European journal of clinical pharmacology 8 (73), pp. 973-980 |
|
| 76. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. | Tempark, T Satapornpong, P Rerknimitr, P Nakkam, N Saksit, N Wattanakrai, P Jantararoungtong, T Koomdee, N Mahakkanukrauh, A Tassaneeyakul, W Suttisai, S Pratoomwun, J Klaewsongkram, J Rerkpattanapipat, T Sukasem, C |
2017 |
Pharmacogenetics and genomics 12 (27), pp. 429-437 |
|
| 77. | Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population. | Koomdee, N Pratoomwun, J Jantararoungtong, T Theeramoke, V Tassaneeyakul, W Klaewsongkram, J Rerkpattanapipat, T Santon, S Puangpetch, A Intusoma, U Tempark, T Deesudchit, T Satapornpong, P Visudtibhan, A Sukasem, C |
2017 |
Frontiers in pharmacology (8), pp. 879 |
|
| 78. | Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia. | Khuankaew, C Apaijai, N Sawaddiruk, P Jaiwongkam, T Kerdphoo, S Pongsiriwet, S Tassaneeyakul, W Chattipakorn, N Chattipakorn, SC |
2018 |
Free radical research (), pp. 1-181 |
|
| 79. | New Advances in Drug Hypersensitivity Research and Treatment. | Tsai, YG Chung, WH Abe, R Tassaneeyakul, W |
2018 |
Journal of immunology research (2018), pp. 9345078 |
|
| 80. | Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. | Nakkam, N Konyoung, P Kanjanawart, S Saksit, N Kongpan, T Khaeso, K Khunarkornsiri, U Dornsena, A Tassaneeyakul, W Tassaneeyakul, W |
2018 |
Frontiers in genetics (9), pp. 277 |
|
| 81. | Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population. | Chong, HY Lim, YH Prawjaeng, J Tassaneeyakul, W Mohamed, Z Chaiyakunapruk, N |
2018 |
Pharmacogenetics and genomics 2 (28), pp. 56-67 |
|
| 82. | HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. | Su, SC Chen, CB Chang, WC Wang, CW Fan, WL Lu, LY Nakamura, R Saito, Y Ueta, M Kinoshita, S Sukasem, C Yampayon, K Kijsanayotin, P Nakkam, N Saksit, N Tassaneeyakul, W Aihara, M Lin, YJ Chang, CJ Wu, T Hung, SI Chung, WH |
2019 |
Clinical pharmacology and therapeutics 2 (105), pp. 476-485 |
|
| 83. | Identification of drug-specific public TCR driving severe cutaneous adverse reactions. | Pan, RY Chu, MT Wang, CW Lee, YS Lemonnier, F Michels, AW Schutte, R Ostrov, DA Chen, CB Phillips, EJ Mallal, SA Mockenhaupt, M Bellón, T Tassaneeyakul, W White, KD Roujeau, JC Chung, WH Hung, SI |
2019 |
Nature communications 1 (10), pp. 3569 |
|
| 84. | Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect. | Leong, SL Chaiyakunapruk, N Tassaneeyakul, W Arunmanakul, P Nathisuwan, S Lee, SWH |
2019 |
International journal of cardiology (280), pp. 190-197 |
|
| 85. | The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label. | Wang, YH Chen, CB Tassaneeyakul, W Saito, Y Aihara, M Choon, SE Lee, HY Chang, MM Roa, FD Wu, CW Zhang, J Nakkam, N Konyoung, P Okamoto-Uchida, Y Cheung, CM Huang, JW Ji, C Cheng, B Hui, RC Chu, CY Chen, YJ Wu, CY Hsu, CK Chiu, TM Huang, YH Lu, CW Yang, CY Lin, YT Chi, MH Ho, HC Lin, JY Yang, CH Chang, YC Su, SC Wang, CW Fan, WL Hung, SI Chung, WH , |
2019 |
Clinical pharmacology and therapeutics 1 (105), pp. 112-120 |
|
| 86. | Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. | Sukasem, C Pratoomwun, J Satapornpong, P Klaewsongkram, J Rerkpattanapipat, T Rerknimitr, P Lertpichitkul, P Puangpetch, A Nakkam, N Konyoung, P Khunarkornsiri, U Disphanurat, W Srisuttiyakorn, C Pattanacheewapull, O Kanjanawart, S Kongpan, T Chumworathayi, P Saksit, N Bruminhent, J Tassaneeyakul, W Chantratita, W Pirmohamed, M |
2020 |
Clinical pharmacology and therapeutics 5 (108), pp. 1078-1089 |
|
| 87. | Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing . | Pratoomwun, J Thomson, P Jaruthamsophon, K Tiyasirichokchai, R Jinda, P Rerkpattanapipat, T Tassaneeyakul, W Nakkam, N Rerknimitr, P Klaewsongkram, J Srinoulprasert, Y Pirmohamed, M Naisbitt, DJ Sukasem, C |
2021 |
Frontiers in immunology (12), pp. 658593 |
|
| 88. | Meta-Analysis of Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations. | Khaeso, K Udayachalerm, S Komvilaisak, P Chainansamit, SO Suwannaying, K Laoaroon, N Kuwatjanakul, P Nakkam, N Sukasem, C Puangpetch, A Tassaneeyakul, W Chaiyakunapruk, N |
2021 |
Frontiers in pharmacology (12), pp. 784712 |
|
| 89. | The Thai reference exome (T-REx) variant database. | Shotelersuk, V Wichadakul, D Ngamphiw, C Srichomthong, C Phokaew, C Wilantho, A Pakchuen, S Nakhonsri, V Shaw, PJ Wasitthankasem, R Piriyapongsa, J Wangkumhang, P Assawapitaksakul, A Chetruengchai, W Lapphra, K Khuninthong, A Makarawate, P Suphapeetiporn, K Mahasirimongkol, S Satproedprai, N Porntaveetus, T Pisitkun, P Praphanphoj, V Kantaputra, P Tassaneeyakul, W Tongsima, S |
2021 |
Clinical genetics 6 (100), pp. 703-712 |
|
| 90. | Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients. | Khaeso, K Nakkam, N Komwilaisak, P Wongmast, P Chainansamit, SO Dornsena, A Kanjanawart, S Vannaprasaht, S Tassaneeyakul, W |
2021 |
Journal of pediatric genetics 1 (10), pp. 29-34 |
|
| 91. | Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. | Wang, CW Tassaneeyakul, W Chen, CB Chen, WT Teng, YC Huang, CY Sukasem, C Lu, CW Lee, YS Choon, SE Nakkam, N Hui, RC Huang, YH Chang, YC Lin, YY Chang, CJ Chiu, TM Chantratita, W Konyoung, P Lee, CN Klaewsongkram, J Rerkpattanapipat, T Amornpinyo, W Saksit, N Rerknimitr, P Huang, YH Lin, SH Hsu, CK Chan, CC Lin, YJ Hung, SI Chung, WH , |
2021 |
The Journal of allergy and clinical immunology 4 (147), pp. 1402-1412 |
|
| 92. | Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. | Satapornpong, P Pratoomwun, J Rerknimitr, P Klaewsongkram, J Nakkam, N Rungrotmongkol, T Konyoung, P Saksit, N Mahakkanukrauh, A Amornpinyo, W Khunarkornsiri, U Tempark, T Wantavornprasert, K Jinda, P Koomdee, N Jantararoungtong, T Rerkpattanapipat, T Wang, CW Naisbitt, D Tassaneeyakul, W Ariyachaipanich, M Roonghiranwat, T Pirmohamed, M Chung, WH Sukasem, C |
2021 |
Frontiers in immunology (12), pp. 661135 |
|
| 93. | Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome. | Chomean, S Nakkam, N Tassaneeyakul, W Attapong, J Kaset, C |
2022 |
Analytical biochemistry (658), pp. 114931 |
|
| 94. | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine. | Nakkam, N Konyoung, P Amornpinyo, W Saksit, N Tiamkao, S Khunarkornsiri, U Khaeso, K Pattanacheewapull, O Jorns, TP Chumworathayi, P Tassaneeyakul, W |
2022 |
British journal of clinical pharmacology 2 (88), pp. 773-786 |
|
| 95. | NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. | Khaeso, K Komvilaisak, P Chainansamit, SO Nakkam, N Suwannaying, K Kuwatjanakul, P Hikino, K Dornsena, A Kanjanawart, S Laoaroon, N Vannaprasaht, S Taketani, T Tassaneeyakul, W |
2022 |
Drug metabolism and pharmacokinetics (43), pp. 100436 |
|
| 96. | Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions. | Nakkam, N Saksit, N Konyoung, P Amornpinyo, W Khunarkornsiri, U Purimart, D Pattanacheewapull, O Naewla, T Wattanachai, P Khaeso, K Chumworathayi, P Tassaneeyakul, W |
2022 |
Drug metabolism and pharmacokinetics (47), pp. 100480 |
|
| 97. | Association between alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions. | Wattanachai, P Amornpinyo, W Konyoung, P Purimart, D Khunarkornsiri, U Pattanacheewapull, O Tassaneeyakul, W Nakkam, N |
2023 |
Frontiers in pharmacology (14), pp. 1248386 |
|
| 98. | Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand. | Kategeaw, W Nakkam, N Kiertiburanakul, S Sukasem, C Tassaneeyakul, W Chaiyakunapruk, N |
2023 |
Journal of medical economics 1 (26), pp. 1330-1341 |
|
| 99. | Complete mitochondrial genomes of patients from Thailand with cardiovascular diseases. | Woravatin, W Wongkomonched, R Tassaneeyakul, W Stoneking, M Makarawate, P Kutanan, W |
2024 |
PloS one 7 (19), pp. e0307036 |
|
| 100. | Dual approaches in pharmacogenetics: Developing PCR-SSP and RT-PCR methods for HLA-B*13:01 screening to prevent dapsone and Co-trimoxazole SCARs. | Attapong, J Kaset, C Nakkam, N Tassaneeyakul, W Wichukchinda, N Chomean, S |
2024 |
Heliyon 15 (10), pp. e34977 |
|
| 101. | Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. | Settheetham-Ishida, W Yuenyao, P Tassaneeyakul, W Kanjanavirojkul, N Thawmor, A Kularbkaew, C Hahvajanawong, C Settheetham, D Wattanathorn, J Kashima, T Ishida, T |
Asian Pacific journal of cancer prevention : APJCP 1 (7), pp. 113-8 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Arylamine N-acetyltransferase-2 genotypes in the Thai population | V Kukongviriyapan A Prawan W Tassaneyakul J Aiemsa-ard B Warasiha |
2003 |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 3.0 (55.0), pp. 278.0-281.0 |
43 | 0 | 0 | 0 | 0 | 0 | 43 | |
| 2. | Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population | V Kukongviriyapan A Prawan B Warasiha W Tassaneyakul J Aiemsa-ard |
2003 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 4.0 (59.0), pp. 277.0-281.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 3. | Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines | Nisana Tepsiri Liengchai Chaturat Banchob Sripa Wises Namwat Sopit Wongkham Vajarabhongsa Bhudhisawasdi Wichittra Tassaneeyakul |
2005 |
WORLD JOURNAL OF GASTROENTEROLOGY 18.0 (11.0), pp. 2748.0-2753.0 |
71 | 0 | 0 | 0 | 0 | 0 | 71 | |
| 4. | Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines | Nisana N. Tepsiri Watcharin Loilome Piyawan Amimanan Patcharee Jearanaikoon Wichittra Tassaneeyakul |
2006 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (21.0), pp. A95-A95 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations | Wichittra Tassaneeyakul Werawath Mahatthanatrakul Kanokporn Niwatananun Kesara Na-Bangchang Arporn Tawalee Nathawut Krikreangsak Utaiwan Cykleng Wongwiwat Tassaneeyakul |
2006 |
DRUG METABOLISM AND PHARMACOKINETICS 4.0 (21.0), pp. 286.0-290.0 |
46 | 0 | 0 | 0 | 0 | 0 | 46 | |
| 6. | Effect of B-thalassemia/HbE disease on activity of cytochrome P450s | Nuntiya Somparn Veerapol Kukongviriyapan Wichittra Tassaneeyakul Upa Kukongviriyapan Arunee Jetsrisuparb |
2006 |
DRUG METABOLISM REVIEWS (38.0), pp. 116.0-116.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis | Suthipun Jitpimolmard Kittisak Sawanyawisuth Nimit Morakote Athasit Vejjajiva Montien Puntumetakul Kanokwan Sanchaisuriya Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul Narumanas Korwanich |
2007 |
PARASITOLOGY RESEARCH 6.0 (100.0), pp. 1293.0-1296.0 |
77 | 0 | 0 | 0 | 0 | 0 | 77 | |
| 8. | COMPARATIVE BIOAVAILABILITY OF PHENYTOIN SUSPENSION IN THAI HEALTHY VOLUNTEERS | Suda Vannaprasaht Somsak Tiamkao Aporanee Chaiyakum Chedsada Noppawinyoowong Detpon Preechagoon Sirimas Kanjanawat Wichittra Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 93.0-93.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS | Sirimas Kanjanawart Suda Vannaprasaht Panot Tangsucharit Dhanu Gaysornsiri Siriporn Tiamkao Bunkerd Kongyingyoes Roongpet Tangrassameeprasert Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 87.0-87.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 10. | INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Vichien Attakornvattana Aimon Somanabandhu Suda Vannaprasaht Wongwiwat Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 219.0-219.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 11. | Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients | Nuntiya Somparn Upa Kukongviriyapan Wichittra Tassaneeyakul Arunee Jetsrisuparb Veerapol Kukongviriyapan |
2007 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 1.0 (63.0), pp. 43.0-50.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
| 12. | THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS | Susothorn Angsuthum Wichittra Tassaneeyakul Cholatip Pongskul Dhavee Sirivongs Wongwiwat Tassaneeyakul Yingyos Avihingsanon Suda Vannaprasaht |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 269.0-269.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 13. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines | Nisana Namwat Piyawan Amimanan Watcharin Loilome Patcharee Jearanaikoon Banchob Sripa Vajarabhongsa Bhudhisawasdi Wichittra Tassaneeyakul |
2008 |
CHEMOTHERAPY 5.0 (54.0), pp. 343.0-351.0 |
48 | 0 | 0 | 0 | 0 | 0 | 48 | |
| 14. | GENETIC POLYMORPHISM OF DRUG METABOLIZING ENZYMES IN THAIS | Wichittra Tassaneeyakul | 2008 |
DRUG METABOLISM REVIEWS (40.0), pp. 16.0-16.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | CADMIUM EXPOSURE IN THAI POPULATIONS FROM CENTRAL, NORTHERN AND NORTHEASTERN THAILAND AND THE EFFECTS OF FOOD CONSUMPTION ON CADMIUM LEVELS | Roongnapa Apinan Soisangwan Satarug Ronnatrai Ruengweerayut Wichittra Tassaneeyakul Kesara Na-Bangchang |
2009 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 1.0 (40.0), pp. 177.0-186.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 16. | Carbamazepine-the Most Common Cause of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and an Association with HLA-B*1502 in a Thai Population | Thawinee Iantararoungtong Somsak Tiamkao Suda Vannaprasaht Kasemsin Pavakul Narong Auvichayapat Charoen Choonhakarn Wichittra Tassaneeyakul |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 57.0-57.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 17. | CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking | Wiratchanee Mahavorasirikul Wichittra Tassaneeyakul Soisagwan Satarug Ronnatrai Reungweerayut Chacrin Na-Bangchang Kesara Na-Bangchang |
2009 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 4.0 (65.0), pp. 377.0-384.0 |
19 | 0 | 0 | 0 | 0 | 0 | 19 | |
| 18. | Effect of Albumin on In Vitro Omeprazole Kinetics in Human Liver Microsomes | Nitsupa Wattanachai David J. Elliot Wichittra Tassaneeyakul John O. Miners |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 32.0-32.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 19. | Expression Profile of Genes Involved in 5-Fluorouracil Metabolic Pathway as Predictive Parameters for 5-Fluorouracil Response in Cholangiocarcinoma | Jariya Chaiyagool Chariya Hahnvajanawong Banchob Sripa Vajarapong Bhudhisawasdi Narong Khuntikeo Ake Pugkhem Siri Chau-in Wichittra Tassaneeyakul |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 40.0-40.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 20. | Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand | Suda Vannaprasaht Susothorn Angsuthum Yingyos Avihingsanon Dhavee Sirivongs Cholatip Pongskul Pattarapong Makarawate Kearkiat Praditpornsilpa Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2009 |
CLINICAL THERAPEUTICS 7.0 (31.0), pp. 1524.0-1533.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
| 21. | Influence of Genetic and Environmental Factors on Cytochrome P450-mediated Nicotine Metabolism in Thai Population | Wiratchanee Mahavorasirikul Rungnapa Apinan Soisungwan Satarug Wichittra Tassaneeyakul Kesara Na-Bangchang |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 75.0-75.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22. | Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus | Theerada Taesotikul Aimon Somanabandhu Vichien Navinpipatana Sirimas Kanjanawart Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 39.0-39.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 23. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Wichittra Tassaneeyakul Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Somsak Tiamkao Usanee Khunarkornsiri Pachadaporn Chucherd Parinya Konyoung Suda Vannaprasaht Charoen Choonhakarn Pornrith Pisuttimarn Alisara Sangviroon Wongwiwat Tassaneeyakul |
2009 |
PHARMACOGENETICS AND GENOMICS 9.0 (19.0), pp. 704.0-709.0 |
345 | 0 | 0 | 0 | 0 | 0 | 345 | |
| 24. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population | Roongnapa Apinan Wichittra Tassaneeyakul Wiratchanee Mahavorasirikul Soisangwang Satarug Sirimas Kajanawart Suda Vannaprasaht Ronnatrai Ruenweerayut Kesara Na-Bangchang |
2009 |
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 3.0 (28.0), pp. 420.0-424.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 25. | Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 | Wongwiwat Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Pachadaporn Chucherd Suda Vannaprasaht Charoen Choonhakarn Alisara Sangviroon Wichittra Tassaneeyakul |
2010 |
DRUG METABOLISM REVIEWS (42.0), pp. 253.0-254.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines | Chariya Hahnvajanawong Wongwarut Boonyanugomol Tapanawan Nasomyon Watcharin Loilome Nisana Namwat Natthinee Anantachoke Wichittra Tassaneeyakul Banchob Sripa Wises Namwat Vichai Reutrakul |
2010 |
WORLD JOURNAL OF GASTROENTEROLOGY 18.0 (16.0), pp. 2235.0-2243.0 |
39 | 0 | 0 | 0 | 0 | 0 | 39 | |
| 27. | Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population | Wichittra Tassaneeyakul Somsak Tiamkao Thawinee Jantararoungtong Pei Chen Shu-Yi Lin Wei-Hsuan Chen Parinya Konyoung Usanee Khunarkornsiri Narong Auvichayapat Kasemsin Pavakul Kongkiat Kulkantrakorn Charoen Choonhakarn Siranun Phonhiamhan Namfon Piyatrakul Thiti Aungaree Sunsanee Pongpakdee Praphan Yodnopaglaw |
2010 |
EPILEPSIA 5.0 (51.0), pp. 926.0-930.0 |
232 | 0 | 0 | 0 | 0 | 0 | 232 | |
| 28. | Association of HLA-B*1502 and severe cutaneous adverse reactions caused by aromatic antiepileptic drugs | Wichittra Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Shu-Yi Lin Wei-Hsuan Chen Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Alisara Sangviroon Patcharee Kanjanawat Arkhom Arayawhichanont Charoen Choonhakarn Kongkiat Kulkantrakorn |
2010 |
DRUG METABOLISM REVIEWS (42.0), pp. 255.0-255.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 29. | OPTIMISING CLOZAPINE THERAPY: A NEW MODEL OF CLOZAPINE THERAPEUTIC DRUG MONITORING | John Ray Gillian Campbell Tony Richardson Gill Erickson Vaughan Carr Peter Rofe Wichittra Tassaneeyakul Gary Graham |
2010 |
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (44.0), pp. A26-A26 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 30. | Pharmacokinetic and Pharmacodynamic Variation Associated with VKORC1 and CYP2C9 Polymorphisms in Thai Patients Taking Warfarin | Alisara Sangviroon Duangchit Panomvana Wichittra Tassaneeyakul Jule Namchaisiri |
2010 |
DRUG METABOLISM AND PHARMACOKINETICS 6.0 (25.0), pp. 531.0-538.0 |
29 | 0 | 0 | 0 | 0 | 0 | 29 | |
| 31. | The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation | Nitsupa Wattanachai Wichittra Tassaneeyakul Verawan Uchaipichat John O. Miners |
2010 |
DRUG METABOLISM REVIEWS (42.0), pp. 77.0-78.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 32. | Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme | Qiping Feng Suda Vannaprasaht Yi Peng Susothorn Angsuthum Yingyos Avihingsanon Vivien C. Yee Wichittra Tassaneeyakul Richard M. Weinshilboum |
2010 |
BIOCHEMICAL PHARMACOLOGY 7.0 (79.0), pp. 1053.0-1061.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 33. | HLA genetic polymorphism and severe cutaneous adverse drug reactions in a Thai population | Wichittra Tassaneeyakul | 2011 |
DRUG METABOLISM REVIEWS (43.0), pp. 17.0-17.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 34. | Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines | Chariya Hahnvajanawong Supaluk Ketnimit Wongwarut Boonyanugomol Kovit Pattanapanyasat Yaovalux Chamgramol Banchob Sripa Nisana Namwat Khosit Pinmai Wichittra Tassaneeyakul Vichai Reutakul |
2011 |
ASIAN BIOMEDICINE 6.0 (5.0), pp. 775.0-785.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 35. | Inhibition of human CYP1A2 activity by Thai medicinal plants with promising activities against cholangiocarcinoma | Wiratchanee Mahavorasirikul Vithoon Viyanant Wichittra Tassaneeyakul Kesara Na-Bangchang |
2011 |
JOURNAL OF PHARMACOLOGICAL SCIENCES (115.0), pp. 279P-279P |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 36. | Inhibitory Effects of Phyllanthus amarus and Its Major Lignans on Human Microsomal Cytochrome P450 Activities: Evidence for CYP3A4 Mechanism-Based Inhibition | Theerada Taesotikul Weeraya Dumrongsakulchai Nitsupa Wattanachai Vichien Navinpipat Aimon Somanabandhu Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2011 |
DRUG METABOLISM AND PHARMACOKINETICS 2.0 (26.0), pp. 154.0-161.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 37. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Nitsupa Wattanachai Thomas M. Polasek Tahlia M. Heath Verawan Uchaipichat Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul John O. Miners |
2011 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 8.0 (67.0), pp. 815.0-824.0 |
46 | 0 | 0 | 0 | 0 | 0 | 46 | |
| 38. | Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance | Nitsupa Wattanachai Wichittra Tassaneeyakul Andrew Rowland David J. Elliot Kushari Bowalgaha Kathleen M. Knights John O. Miners |
2012 |
DRUG METABOLISM AND DISPOSITION 5.0 (40.0), pp. 982.0-989.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
| 39. | Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats | Theerada Taesotikul Miki Nakajima Wichittra Tassaneeyakul Tsuyoshi Yokoi |
2012 |
XENOBIOTICA 7.0 (42.0), pp. 641.0-648.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 40. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma | Puangrat Yongvanit Emorn Phanomsri Nisana Namwat Jureeporn Kampan Wichittra Tassaneeyakul Watcharin Loilome Anucha Puapairoj Narong Khuntikeo |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 162.0-166.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 41. | High Expression of ABCC1 Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma | Umaporn Srimunta Kanlayanee Sawanyawisuth Ratthaphol Kraiklang Chawalit Pairojkul Anucha Puapairoj Tanin Titipungul Chariya Hahnvajanawong Wichittra Tassaneeyakul Chaisiri Wongkham Sopit Wongkham Kulthida Vaeteewoottacharn |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 125.0-130.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 42. | HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain | Kongkiat Kulkantrakorn Wichittra Tassaneeyakul Somsak Tiamkao Thawinee Jantararoungtong Napat Prabmechai Suda Vannaprasaht Pansu Chumworathayi Pei Chen Paskorn Sritipsukho |
2012 |
PAIN PRACTICE 3.0 (12.0), pp. 202.0-208.0 |
73 | 0 | 0 | 0 | 0 | 0 | 73 | |
| 43. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil | Chariya Hahnvajanawong Jariya Chaiyagool Wunchana Seubwai Vajarabhongsa Bhudhisawasdi Nisana Namwat Narong Khuntikeo Banchob Sripa Ake Pugkhem Wichittra Tassaneeyakul |
2012 |
WORLD JOURNAL OF GASTROENTEROLOGY 30.0 (18.0), pp. 3955.0-3961.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 44. | Suppression of PRKAR1A Expression Enhances Antiproliferative and Apoptotic Effects of Protein Kinase Inhibitors and Chemotherapeutic Drugs on Cholangiocarcinoma Cells | Watcharin Loilome Sirinun Juntana Chadamas Pinitsoontorn Nisana Namwat Wichittra Tassaneeyakul Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 143.0-147.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 45. | The Common Sodium Channel Promoter Haplotype in Thai Symptomatic Brugada Syndrome Patients | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Koo Seok Hwee Edmund Jon Deoon Lee Wichittra Tassaneeyakul |
2012 |
CIRCULATION 23.0 (126.0), pp. 2798.0-2798.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 46. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers | Sirimas Kanjanawart Dhanu Gaysonsiri Katcharin Phunikom Sontaya Simasathiansopon Panot Tangsucharit Suda Vannaprasaht Thanawat Kaewkamson Wichittra Tassaneeyakul |
2013 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 3.0 (51.0), pp. 249.0-254.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 47. | Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation | Suda Vannaprasaht Sirirat Reungjui Darika Supanya Dhavee Sirivongs Cholatip Pongskul Yingyos Avihingsanon Wichittra Tassaneeyakul |
2013 |
CLINICAL THERAPEUTICS 11.0 (35.0), pp. 1762.0-1769.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
| 48. | Relationship Between the HLA-B*1502 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis A Systematic Review and Meta-analysis | Wimonchat Tangamornsuksan Nathorn Chaiyakunapruk Ratchadaporn Somkrua Manupat Lohitnavy Wichittra Tassaneeyakul |
2013 |
JAMA DERMATOLOGY 9.0 (149.0), pp. 1025.0-1032.0 |
104 | 0 | 0 | 0 | 0 | 0 | 104 | |
| 49. | Transcranial Direct Current Stimulation for Treatment of Refractory Childhood Focal Epilepsy | Narong Auvichayapat Alexander Rotenberg Roman Gersner Sudarat Ngodklang Somsak Tiamkao Wichittra Tassaneeyakul Paradee Auvichayapat |
2013 |
BRAIN STIMULATION 4.0 (6.0), pp. 696.0-700.0 |
70 | 0 | 0 | 0 | 0 | 0 | 70 | |
| 50. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Wichittra Tassaneeyakul Kittisak Sawanyawisuth |
2014 |
SINGAPORE MEDICAL JOURNAL 4.0 (55.0), pp. 217.0-220.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 51. | COMPARATIVE ANTIPLATELET AGGREGATION EFFECT OF TWO CLOPIDOGREL PRODUCTS UNDER STEADY STATE CONDITION IN HEALTHY VOLUNTEERS | S. Tiamkao N. Nakkam S. Kanjanawart W. Tassaneeyakul |
2014 |
CEREBROVASCULAR DISEASES (37.0), pp. 341.0-341.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 52. | Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population | Surasak Saokaew Wichittra Tassaneeyakul Ratree Maenthaisong Nathorn Chaiyakunapruk |
2014 |
PLOS ONE 4.0 (9.0), pp. |
81 | 0 | 0 | 0 | 0 | 0 | 81 | |
| 53. | High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis | Suyanee Thongchot Puangrat Yongvanit Watcharin Loilome Wanchana Seubwai Kutcharin Phunicom Wichittra Tassaneeyakul Chawalit Pairojkul Wisuttiphong Promkotra Anchalee Techasen Nisana Namwat |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 14.0 (15.0), pp. 5873.0-5878.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
| 54. | PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jurairat Jongthawin Porncheera Chusorn Anchalee Techasen Watcharin Loilome Thidarut Boonmars Raynoo Thanan Anucha Puapairoj Narong Khuntikeo Wichittra Tassaneeyakul Puangrat Yongvanit Nisana Namwat |
2014 |
TUMOR BIOLOGY 8.0 (35.0), pp. 8051.0-8064.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 55. | Pharmacogenomics of drug-induced hypersensitivity reactions: challenges opportunities and clinical implementation | Chonlaphat Sukasem Apichaya Puangpetch Sadeep Medhasi Wichittra Tassaneeyakul |
2014 |
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY 2.0 (32.0), pp. 111.0-123.0 |
58 | 0 | 0 | 0 | 0 | 0 | 58 | |
| 56. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions | Thachanan Kongpan Surakameth Mahasirimongkol Parinya Konyoung Sirimas Kanjanawart Pansu Chumworathayi Nuanjun Wichukchinda Runglak Kidkeukarun Suphanlinee Preechakul Usanee Khunarkornsiri Warawut Bamrungram Butsaban Supharatwattanakun Piroon Mootsikapun Supanida Kwangsukstid Sukanda Denjanta Suda Vannaprasaht Watcharee Rungapiromnan Wimon Suwankesawong Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 |
PHARMACOGENETICS AND GENOMICS 8.0 (25.0), pp. 402.0-411.0 |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 57. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 |
DRUG METABOLISM AND PHARMACOKINETICS 4.0 (30.0), pp. 295.0-304.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 58. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Wichittra Tassaneeyakul Napat Prabmeechai Chonlaphat Sukasem Thachanan Kongpan Parinya Konyoung Pansu Chumworathayi Somsak Tiamkao Usanee Khunarkornsiri Kongkiat Kulkantrakorn Niwat Saksit Nontaya Nakkam Patompong Satapornpong Suda Vannaprasaht Alisara Sangviroon Surakameth Mahasirimongkol Nuanjun Wichukchinda Ticha Rerkpattanapipat Wongwiwat Tassaneeyakul |
2016 |
PHARMACOGENETICS AND GENOMICS 5.0 (26.0), pp. 225.0-234.0 |
73 | 0 | 0 | 0 | 0 | 0 | 73 | |
| 59. | Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update | Y. Saito L. K. Stamp K. E. Caudle M. S. Hershfield E. M. McDonagh J. T. Callaghan W. Tassaneeyakul T. Mushiroda N. Kamatani B. R. Goldspiel E. J. Phillips T. E. Klein M. T. M. Lee |
2016 |
CLINICAL PHARMACOLOGY & THERAPEUTICS 1.0 (99.0), pp. 36.0-37.0 |
98 | 0 | 0 | 0 | 0 | 0 | 98 | |
| 60. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (31.0), pp. 78.0-78.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 61. | Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population | Napatrupron Koomdee Jirawat Pratoomwun Thawinee Jantararoungtong Voralaksana Theeramoke Wichittra Tassaneeyakul Jettanong Klaewsongkram Ticha Rerkpattanapipat Siwalee Santon Apichaya Puangpetch Utcharee Intusoma Therdpong Tempark Tayard Deesudchit Patompong Satapornpong Anannit Visudtibhan Chonlaphat Sukasem |
2017 |
FRONTIERS IN PHARMACOLOGY (8.0), pp. |
38 | 0 | 0 | 0 | 0 | 0 | 38 | |
| 62. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Kutcharin Phunikhom Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2017 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 2.0 (55.0), pp. 177.0-185.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 63. | Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions | Niwat Saksit Nontaya Nakkam Parinya Konyoung Usanee Khunarkornsiri Wongwiwat Tassaneeyakul Pansu Chumworathayi Sirimas Kanjanawart Chonlaphat Sukasem Alisara Sangviroon Oranuch Pattanacheewapull Wichittra Tassaneeyakul |
2017 |
JOURNAL OF IMMUNOLOGY RESEARCH (2017.0), pp. |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 64. | CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION | Wichittra Tassaneeyakul Parinya Konyoung Thachanan Kongpan Pansu Chumworathayi Nontaya Nakkam Suda Vannaprasaht Somsak Tiamkao Chonlaphat Sukasem Patompong Satapornpong Wongwiwat Tassaneeyakul |
2017 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (32.0), pp. S85-S86 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 65. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13:01 allele in the Thai population | Therdpong Tempark Patompong Satapornpong Pawinee Rerknimitr Nontaya Nakkam Niwat Saksit Penpun Wattanakrai Thawinee Jantararoungtong Napatrupron Koomdee Ajanee Mahakkanukrauh Wichittra Tassaneeyakul Sumitra Suttisai Jirawat Pratoomwun Jettanong Klaewsongkram Ticha Rerkpattanapipat Chonlaphat Sukasem |
2017 |
PHARMACOGENETICS AND GENOMICS 12.0 (27.0), pp. 429.0-437.0 |
80 | 0 | 0 | 0 | 0 | 0 | 80 | |
| 66. | DEVELOPMENT OF A PHARMACOGENETICS-BASED WARFARIN DOSING ALGORITHM FOR THAI PATIENTS | Nitsupa Wattanachai Sutthida Kaewmoongkun Wichittra Tassaneeyakul |
2017 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (32.0), pp. S86-S86 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 67. | GENETIC MARKERS FOR SEVERE CUTANEOUS ADVERSE DRUG REACTIONS IN THAI POPULATION AND THEIR CLINICAL STATUS | Wichittra Tassaneeyakul | 2017 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (32.0), pp. S16-S16 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 68. | HAPLOTYPE OF HLA-B*13:01/HLA-B*15:02 AND DAPSONE-INDUCED DRUG HYPERSENSITIVITY SYNDROME IN THAI | Chonlaphat Sukasem Therdpong Tempark Patompong Satapornpong Pawinee Rerknimitr Jettanong Klaewsongkram Wichittra Tassaneeyakul |
2017 |
HLA 6.0 (89.0), pp. 470.0-471.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 69. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance | Supak Yothaisong Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Anucha Puapairoj Promsuk Jutabha Naohiko Anzai Wichittra Tassaneeyakul Panot Tangsucharit Watcharin Loilome |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 471.0-478.0 |
21 | 0 | 0 | 0 | 0 | 0 | 21 | |
| 70. | Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians | Chun-Bing Chen Yi-Hsin Hsiao Tony Wu Mo-Song Hsih Wichittra Tassaneeyakul Teekayu P. Jorns Chonlaphat Sukasem Chien-Ning Hsu Shih-Chi Su Wan-Chun Chang Rosaline Chung-Yee Hui Chia-Yu Chu Yi-Ju Chen Ching-Ying Wu Chao-Kai Hsu Tsu-Man Chiu Pei-Lun Sun Hua-En Lee Chin-Yi Yang Pei-han Kao Chih-Hsun Yang Hsin-Chun Ho Jing-Yi Lin Ya-Ching Chang Ming-Jing Chen Chun-Wei Lu Chau Yee Ng Kang-Ling Kuo Chien-yio Lin Ching-Sheng Yang Ding-Ping Chen Pi-Yueh Chang Tsu-Lan Wu Yu-Jr Lin Yi-Ching Weng Tseng-tong Kuo Shuen-Iu Hung Wen-Hung Chung |
2017 |
NEUROLOGY 1.0 (88.0), pp. 78.0-86.0 |
119 | 0 | 0 | 0 | 0 | 0 | 119 | |
| 71. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Niwat Saksit Wichittra Tassaneeyakul Nontaya Nakkam Parinya Konyoung Usanee Khunarkornsiri Pansu Chumworathayi Chonlaphat Sukasem Sumitra Suttisai Napacha Piriyachananusorn Pawinee Tiwong Nathorn Chaiyakunapruk Kittisak Sawanyawisuth Ticha Rerkpattanapipat Wongwiwat Tassaneeyakul |
2017 |
PHARMACOGENETICS AND GENOMICS 7.0 (27.0), pp. 255.0-263.0 |
29 | 0 | 0 | 0 | 0 | 0 | 29 | |
| 72. | SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Dujdao Sahasthas Seok Hwee Koo Edmund Jon Deoon Lee Wichittra Tassaneeyakul Hector Barajas-Martinez Dan Hu Kittisak Sawanyawisuth |
2017 |
JOURNAL OF THE AMERICAN HEART ASSOCIATION 6.0 (6.0), pp. |
33 | 0 | 0 | 0 | 0 | 0 | 33 | |
| 73. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients | Nitsupa Wattanachai Sutthida Kaewmoongkun Burabha Pussadhamma Pattarapong Makarawate Chaiyasith Wongvipaporn Songsak Kiatchoosakun Suda Vannaprasaht Wichittra Tassaneeyakul |
2017 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 8.0 (73.0), pp. 973.0-980.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 74. | Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population | Huey Yi Chong Yi Heng Lim Juthamas Prawjaeng Wichittra Tassaneeyakul Zahurin Mohamed Nathorn Chaiyakunapruk |
2018 |
PHARMACOGENETICS AND GENOMICS 2.0 (28.0), pp. 56.0-67.0 |
28 | 0 | 0 | 0 | 0 | 0 | 28 | |
| 75. | Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminai neuralgia | Chutikorn Khuankaew Nattayaporn Apaijai Passakorn Sawaddiruk Thidarat Jaiwongkann Sasiwan Kerdphoo Surawut Pongsiriwet Wichittra Tassaneeyakul Nipon Chattipakorn Siriporn C. Chattipakorn |
2018 |
FREE RADICAL RESEARCH 4.0 (52.0), pp. 415.0-425.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 76. | HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population | Nontaya Nakkam Parinya Konyoung Sirimas Kanjanawart Niwat Saksit Thachanan Kongpan Kanyarat Khaeso Usanee Khunarkornsiri Areerat Domsena Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2018 |
FRONTIERS IN GENETICS (9.0), pp. |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 77. | New Advances in Drug Hypersensitivity Research and Treatment | Yi-Giien Tsai Wen-Hung Chung Riichiro Abe Wichittra Tassaneeyakul |
2018 |
JOURNAL OF IMMUNOLOGY RESEARCH (2018.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 78. | HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians | Shih-Chi Su Chun-Bing Chen Wan-Chun Chang Chuang-Wei Wang Wen-Lang Fan Lai-Ying Lu Ryosuke Nakamura Yoshiro Saito Mayumi Ueta Shigeru Kinoshita Chonlaphat Sukasem Kittika Yampayon Pornpimol Kijsanayotin Nontaya Nakkam Niwat Saksit Wichittra Tassaneeyakul Michiko Aihara Yu- Lin Chee-Jen Chang Tony Wu Sheen-Iu Hung Wen-Hung Chung |
2019 |
CLINICAL PHARMACOLOGY & THERAPEUTICS 2.0 (105.0), pp. 476.0-485.0 |
39 | 0 | 0 | 0 | 0 | 0 | 39 | |
| 79. | Identification of drug-specific public TCR driving severe cutaneous adverse reactions | Ren-You Pan Mu-Tzu Chu Chuang-Wei Wang Yun-Shien Lee Francois Lemonnier Aaron W. Michels Ryan Schutte David A. Ostrov Chun-Bing Chen Elizabeth Jane Phillips Simon Alexander Mallal Maja Mockenhaupt Teresa Bellon Wichittra Tassaneeyakul Katie D. White Jean-Claude Roujeau Wen-Hung Chung Shuen-Iu Hung |
2019 |
NATURE COMMUNICATIONS (10.0), pp. |
45 | 0 | 0 | 0 | 0 | 0 | 45 | |
| 80. | Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect | Siew Lian Leong Nathorn Chaiyakunapruk Wichittra Tassaneeyakul Poukwan Arunmanakul Surakit Nathisuwan Shaun Wen Huey Lee |
2019 |
INTERNATIONAL JOURNAL OF CARDIOLOGY (280.0), pp. 190.0-197.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 81. | The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label | Yu-Hsin Wang Chun-Bing Chen Wichittra Tassaneeyakul Yoshiro Saito Michiko Aihara Siew Eng Choon Haur Yueh Lee Mimi Mee Chang Francisca D. Roa Cheng-Wei Wu Jing Zhang Nontaya Nakkam Parinya Konyoung Yoshimi Okamoto-Uchida Christina Man-tung Cheung Jin-wen Huang Chao Ji Bo Cheng Rosaline Chung-Yee Hui Chia-Yu Chu Yi-Ju Chen Ching-Ying Wu Chao-Kai Hsu Tsu-Man Chiu Yu-Huei Huang Chun-Wei Lu Chin-Yi Yang Yi-Ting Lin Min-Hui Chi Hsin-Chun Ho Jing-Yi Lin Chih-Hsun Yang Ya-Ching Chang Shih-Chi Su Chuang Wei Wang Wen-Lang Fan Shuen-Iu Hung Wen-Hung Chung |
2019 |
CLINICAL PHARMACOLOGY & THERAPEUTICS 1.0 (105.0), pp. 112.0-120.0 |
41 | 0 | 0 | 0 | 0 | 0 | 41 | |
| 82. | Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes | Chonlaphat Sukasem Jirawat Pratoomwun Patompong Satapornpong Jettanong Klaewsongkram Ticha Rerkpattanapipat Pawinee Rerknimitr Pattamon Lertpichitkul Apichaya Puangpetch Nontaya Nakkam Parinya Konyoung Usanee Khunarkornsiri Wareeporn Disphanurat Chutika Srisuttiyakorn Oranuch Pattanacheewapull Sirimas Kanjanawart Thachanan Kongpan Pansu Chumworathayi Niwat Saksit Jackrapong Bruminhent Wichittra Tassaneeyakul Wasun Chantratita Munir Pirmohamed |
2020 |
CLINICAL PHARMACOLOGY & THERAPEUTICS 5.0 (108.0), pp. 1078.0-1089.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 83. | Prevalence of CYP2C19, CYP3A4 and FMO3 genetic polymorphisms in healthy northeastern Thai volunteers | Thikhumporn Areesinpitak Sirimas Kanjanawart Nontaya Nakkam Wichittra Tassaneeyakul Suda Vannaphasaht |
2020 |
SCIENCEASIA 4.0 (46.0), pp. 397.0-402.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 84. | Protective Effects of Purple Waxy Corn on Aflatoxin B1-induced Oxidative Stress and Micronucleus in HepG2 Cells | T. Singto W. Tassaneeyakul S. Porasuphatana |
2020 |
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES 3.0 (82.0), pp. 506.0-513.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 85. | Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01 | Jirawat Pratoomwun Paul Thomson Kanoot Jaruthamsophon Rawiporn Tiyasirichokchai Pimonpan Jinda Ticha Rerkpattanapipat Wichittra Tassaneeyakul Nontaya Nakkam Pawinee Rerknimitr Jettanong Klaewsongkram Yuttana Srinoulprasert Munir Pirmohamed Dean J. Naisbitt Chonlaphat Sukasem |
2021 |
FRONTIERS IN IMMUNOLOGY (12.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 86. | Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients | Kanyarat Khaeso Nontaya Nakkam Patcharee Komwilaisak Piyathida Wongmast Su-on Chainansamit Areerat Dornsena Sirimas Kanjanawart Suda Vannaprasaht Wichittra Tassaneeyakul |
2021 |
JOURNAL OF PEDIATRIC GENETICS 1.0 (10.0), pp. 29.0-34.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 87. | Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine | Nontaya Nakkam Parinya Konyoung Warayuwadee Amornpinyo Niwat Saksit Somsak Tiamkao Usanee Khunarkornsiri Kanyarat Khaeso Oranuch Pattanacheewapull Teekayu Plangkoon Jorns Pansu Chumworathayi Wichittra Tassaneeyakul |
2021 |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 88. | HLA-B*13:01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Patompong Satapornpong Jirawat Pratoomwun Pawinee Rerknimitr Jettanong Klaewsongkram Nontaya Nakkam Thanyada Rungrotmongkol Parinya Konyoung Niwat Saksit Ajanee Mahakkanukrauh Warayuwadee Amornpinyo Usanee Khunarkornsiri Therdpong Tempark Kittipong Wantavornprasert Pimonpan Jinda Napatrupron Koomdee Thawinee Jantararoungtong Ticha Rerkpattanapipat Chuang-Wei Wang Dean Naisbitt Wichittra Tassaneeyakul Manasalak Ariyachaipanich Thapana Roonghiranwat Munir Pirmohamed Wen-Hung Chung Chonlaphat Sukasem |
2021 |
FRONTIERS IN IMMUNOLOGY (12.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 89. | Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations | Kanyarat Khaeso Sariya Udayachalerm Patcharee Komvilaisak Su-on Chainansamit Kunanya Suwannaying Napat Laoaroon Pitchayanan Kuwatjanakul Nontaya Nakkam Chonlaphat Sukasem Apichaya Puangpetch Wichittra Tassaneeyakul Nathorn Chaiyakunapruk |
2021 |
FRONTIERS IN PHARMACOLOGY (12.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 90. | The Thai reference exome (T-REx) variant database | Vorasuk Shotelersuk Duangdao Wichadakul Chumpol Ngamphiw Chalurmpon Srichomthong Chureerat Phokaew Alisa Wilantho Sujiraporn Pakchuen Vorthunju Nakhonsri Philip James Shaw Rujipat Wasitthankasem Jittima Piriyapongsa Pongsakorn Wangkumhang Adjima Assawapitaksakul Wanna Chetruengchai Keswadee Lapphra Athiphat Khuninthong Pattarapong Makarawate Kanya Suphapeetiporn Surakameth Mahasirimongkol Nusara Satproedprai Thantrira Porntaveetus Prapaporn Pisitkun Verayuth Praphanphoj Piranit Kantaputra Wichittra Tassaneeyakul Sissades Tongsima |
2021 |
CLINICAL GENETICS 6.0 (100.0), pp. 703.0-712.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 91. | Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians | Chuang-Wei Wang Wichittra Tassaneeyakul Chun-Bing Chen Wei-Ti Chen Yu-Chuan Teng Cheng-Yang Huang Chonlaphat Sukasem Chun-Wei Lu Yun-Shien Lee Siew-Eng Choon Nontaya Nakkam Rosaline Chung-Yee Hui Yen-Hua Huang Ya-Ching Chang Yang Yu-Wei Lin Chee-Jen Chang Tsu-Man Chiu Wasun Chantratita Parinya Konyoung Chaw-Ning Lee Jettanong Klaewsongkram Ticha Rerkpattanapipat Warayuwadee Amornpinyo Niwat Saksit Pawinee Rerknimitr Yu Huei Huang Shang-Hung Lin Chao-Kai Hsu Cheng-Chi Chan Yu- Lin Shuen-Iu Hung Wen-Hung Chung |
2021 |
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 4.0 (147.0), pp. 1402.0-1412.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Towards Understanding Cytochromes P450 | Wichittra Tassaneeyakul Wongwiwat Tassaneeyakul Khan Kaen Khon Kaen University |
1996 |
Thai Journal of Pharmacology (18), pp. 43-65 |
|
| 2. | Antigastric Ulcer Effect of Turmeric in Rats | Patchareewan Pannangpetch Jintanaporn Watanathorn Orapin Phasuriwong Wichittra Tassaneeyakul Bunkerd Kongyingyoes |
2000 |
Srinagarind Medical Journal (15 No 4), pp. 250-254 |
|
| 3. | Genetic Polymorphism of Cytochrome P450 2C19 | Wichittra Tassaneeyakul Arporn Tawalee Wongwiwat Tassaneeyakul |
2000 |
Thai Journal of Pharmacology (22 No 2), pp. 121-136 |
|
| 4. | Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population | Wichittra Tassaneeyakul Arpom Tawalee Veerapol Kukongviriyapan Wongwiwat Tassaneeyakul |
2000 |
Thai Journal of Pharmacology Supplement 1 (22), pp. S79 |
|
| 5. | Arylamine N-Acetyltransferase-2 Genotype Polymorphism in Thai Population | Auemduan Prawan Veerapol Kukongviriyapan Wichittra Tassaneeyakul Bunkerd Kongyingyose Thailand 40002 Khon Kaen |
2001 |
Thai Journal of Pharmacology Supplement 1 (23), pp. S112 |
|
| 6. | Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers | Wongwiwat Tassaneeyakul Arporn Tawalee Watchara Boonsawat Katcharin Phunikom Veerapol Kukongviriyapan Prapawadee Puapairoj Wichittra Tassaneeyakul |
2002 |
Srinagarind Medical Journal (17 No 4), pp. 254-260 |
|
| 7. | Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population | Somrudee Srimartpirom Wongwiwat Tassaneeyakul Veerapol Kukongwiriyapan Wichittra Tassaneeyakul |
2002 |
Thai Journal of Pharmacology Supplement 1 (24), pp. 137 |
|
| 8. | Screening for Naturally Occurring Inhibitors of Arylamine N-Acetyltransferase 1 Activity | Ninatthanan Phromsopha Veerapol Kukongviriyapan Wichittra Tassaneeyakul Upa Kukongviriyapan |
2002 |
Thai Journal of Pharmacology Supplement 1 (24), pp. 139 |
|
| 9. | Evaluation of CYP1A2 Activity in Thalassemia Patients | Veerapol Kukongviriyapan Laddawan Senggunprai Upa Kukongviriyapan Arunee Jetsrisuparb Wichittra Tassaneyakul Khon Kaen 40002 Khon Kaen University |
2003 |
Thai Journal of Pharmacology (25 No 1), pp. 80 |
|
| 10. | Oxidative Stress and Protein Damage in Thalassemia Patients and Smokers | Nuntiya Somparn Veerapol Kukongviriyapan Wichitra Tassaneeyakul Upa Kukongviriyapan KhonKaen Khon Kaen University |
2004 |
Thai Journal of Pharmacology (26 No 1), pp. 62 |
|
| 11. | Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines | Nisana Namwat Banchob Sripa Watcharin Loilome Vajarabhongsa Bhudisawadi Wichittra Tassaneeyakul |
2007 |
Srinagarind Medical Journal (22 No 3), pp. 230-234 |
|
| 12. | Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients | Wichittra Tassaneeyakul Khanogwan Kittiwattanagul Siriporn Tiamkao Jureeporn Kampan Suda Vannaprasaht Wannapa Haewdee Prapawadee Puapairoj Bunkerd Kongyingyoes Wongwiwat Tassaneeyakul |
2007 |
Srinagarind Medical Journal (22 No 1), pp. 16-23 |
|
| 13. | Herb and Drug Interaction | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Wongwiwat Tassaneeyakul |
2008 |
Srinagarind Medical Journal (23 No 2), pp. 223-228 |
|
| 14. | Bioequivalence and Pharmacokinetic Study of Sildenafil in Healthy Thai Male Volunteers | Sirimas Kanjanawart Bunkerd Kongyingyoes Dhanu Gaysornsiri Panot Tangsucharit Prapawadee Puapairoj Suda Vannaprasaht Siriporn Tiamkao Wichittra Tassaneeyakul |
2008 |
Srinagarind Medical Journal (23 No 1), pp. 38-44 |
|
| 15. | Monoclonal Antibody: Targeted Therapy of Cancer | Sirimas Kanjanawart Wichittra Tassaneeyakul |
2008 |
Srinagarind Medical Journal (23 No 4), pp. 440-446 |
|
| 16. | Pharmacogenomics | Wichittra Tassaneeyakul | 2009 |
Srinagarind Medical Journal (24 No 1), pp. 64-71 |
|
| 17. | Carbamazepine- but not Phenytoin-induced Severe Cutaneous Adverse Drug Reactions are Associated with HLA-B*1502 in a Thai Population | Napat Prabmeechai Somsak Tiamkao Thawinee Jantararoungtong Pansu Chumworathayi Piyameth Dilokthornsakul Wichittra Tassaneeyakul |
2010 |
Thai Journal of Pharmacology (32 No 1), pp. 242-245 |
|
| 18. | Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation | Hasaya Dokduang Nisana Namwat Apinya Jusakul Vajarabhongsa Bhudisawadi Watcharin Loilome Puangrat Yongvanit Banchob Sripa Wichittra Tassaneeyakul |
2010 |
Srinagarind Medical Journal (25 No 1), pp. 2-5 |
|
| 19. | Selective Inhibition of Human Cytochrome P450 1A2 by Moringa oleifera | Theerada Taesotikul Vichien Navinpipatana Wichittra Tassaneeyakul |
2010 |
Thai Journal of Pharmacology (32 No 1), pp. 256-258 |
|
| 20. | Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data | Nitsupa Wattanachai David J. Elliot Verawan Uchaipichat Wichittra Tassaneeyakul John O. Miners |
2010 |
Thai Journal of Pharmacology (32 No 1), pp. 246-249 |
|
| 21. | Bioequivalence of 400 mg Moxifloxacin Tablet in Healthy Thai Volunteers | Sirimas Kanjanawart Sontaya Simasathiansopon Prapawadee Paupairoj Suda Vannaprasath Siriporn Tiamkao Dhanu Gaysonsiri Panot Tangsucharit Thanawat Kaewkamson Wichittra Tassaneeyakul |
2010 |
Thai Journal of Pharmacology (32 No 1), pp. 253-255 |
|
| 22. | Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines | Chariya Hahnvajanawong Vajarabhongsa Bhudisawadi Nisana Namwat Banchob Sripa Wichittra Tassaneeyakul |
2011 |
Srinagarind Medical Journal (26 No 1), pp. 2-8 |
|
| 23. | Role of Human Leukocyte Antigens on Severe Cutaneous Drug Reactions | Thachanan Kongpan Usanee Khunakornsiri Prarinya Konyoung Pansu Chumworathayi Napat Pabmeechai Sirimas Kanjanawart Wichittra Tassaneeyakul |
2013 |
Srinagarind Medical Journal (28 No 1), pp. 120-130 |
|
| 24. | Pharmacology and Factors Affecting the Therapeutic Efficacy of Clopidogrel | Nontaya Nakkam Sirimas Kanjanawart Somsak Tiamkao Wichittra Tassaneeyakul |
2014 |
Srinagarind Medical Journal (29 No 1), pp. 59-70 |
|
| 25. | Incidence of Drug induced-Acute Generalized Exanthematous Pustulosis (AGEP) Reported in Udonthani Hospital | Prarinya Konyoung Wichittra Tassaneeyakul |
2014 |
Srinagarind Medical Journal (29 No 3), pp. 283-287 |
|
| 26. | HLA-B*58:01 Genotype is Associated With Risk of Severe Cutaneous Reactions Induced by Allopurinol in Patients Admitted in Udonthani Hospital | Usanee Khunakornsiri Prarinya Konyoung Thachanan Kongpan Supanida Kwangsukstid Sirimas Kanjanawart Wichittra Tassaneeyakul |
2014 |
Srinagarind Medical Journal (29 No 2), pp. 127-132 |
|
| 27. | Determination of Melatonin in Plasma by Liquid-liquid Extraction and High Performance Liquid Chromatography Coupled with Fluorescence Detection and Its Application for Melatonin Pharmacokinetic Study in Humans | Nuttawut Jenjirattithigarn Katcharin Phunikom Thachanan Kongpan Sirimas Kanjanawart Jeffrey Roy Johns Wichittra Tassaneeyakul |
2014 |
Thai Journal of Pharmacology (36 No 2), pp. 5-18 |
|
| 28. | Pharmacology and Factors Affecting the Therapeutic Efficacy of Elopidogrel | Nontaya Nakkam Sirimas Kanjanawart Somsak Tiamkao Wichittra Tassaneeyakul |
2014 |
ศรีนครินทร์เวชสาร (Srinagarind Medical Journal) 1 (29), pp. 59-70 |
|
| 29. | Different Enzyme Cocktail Conditions Successfully Establish Primary Brain Tumor Cell Line Derived from Pilomyxoid Astrocytoma Patient | Wiyada Punjaruk Nitsa Pasasuk Amnat Kitkhuandee Paradee Auvichayapat Wichittra Tassaneeyakul |
2015 |
Srinagarind Medical Journal (30 No 2), pp. 137-148 |
|
| 30. | The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy | Duanggamon Muengsaen Suda Vannaprasaht Wichittra Tassaneeyakul Kritiya Butthongkomvong Thipawan Bowornkitiwong Luangyot Thongthieang Parichart Pongthai Kosin Wirasorn Aumkhae Sookprasert |
2016 |
Srinagarind Medical Journal (31 No 5), pp. 105-108 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship | ||
|---|---|---|---|---|---|---|
| 1. | การวิเคราะห์ลักษณะของเซลล์มะเร็งท่อน้ำดี ที่ดื้อต่อยา gemcitabine และการทำให้เซลล์ที่ดื้อต่อยา gemcitabine กลับไปไวต่อยาโดยใช้ caged xanthones และ rhinacanthin-C |
ผศ.ดร. ศิริมาศ กาญจนวาศ นางจริยา หาญวจนวงศ์ ศ.ดร. วิจิตรา ทัศนียกุล รศ.ดร. นิษณา นามวาท ผศ.ดร. วันชนะ สืบไวย ผศ.ดร.นพ. สุวิน ว่องวัจนะ ศ.ดร. วิชัย ริ้วตระกูล |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2558 | ทุนงบประมาณแผ่นดินประจำปี 2558 |